data_2jtq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jtq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.453 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.622 ' HG ' ' HB3' ' A' ' 53' ' ' GLN . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HB3' ' HG ' ' A' ' 48' ' ' CYS . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.613 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.502 HD11 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HG ' ' HB3' ' A' ' 53' ' ' GLN . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HB3' ' HG ' ' A' ' 48' ' ' CYS . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.453 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.622 ' HG ' ' HB3' ' A' ' 53' ' ' GLN . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HB3' ' HG ' ' A' ' 48' ' ' CYS . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.613 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.502 HD11 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HG ' ' HB3' ' A' ' 53' ' ' GLN . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HB3' ' HG ' ' A' ' 48' ' ' CYS . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.423 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.501 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.46 ' HB ' HG23 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 57' ' ' ALA . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' ASP . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' ILE . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' ALA . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HE2' ' A' ' 82' ' ' LYS . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE2' HD11 ' A' ' 75' ' ' LEU . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 2' ' ' GLU . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 HG13 ' A' ' 44' ' ' VAL . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 5' ' ' ILE . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 57' ' ' ALA . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 57' ' ' ALA . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 75' ' ' LEU . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 29' ' ' VAL . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 HG12 ' A' ' 7' ' ' VAL . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.449 ' C ' HD12 ' A' ' 5' ' ' ILE . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 5' ' ' ILE . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 54' ' ' SER . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.501 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.46 ' HB ' HG23 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 57' ' ' ALA . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' ASP . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' ILE . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' ALA . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HE2' ' A' ' 82' ' ' LYS . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE2' HD11 ' A' ' 75' ' ' LEU . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 2' ' ' GLU . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 HG13 ' A' ' 44' ' ' VAL . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 5' ' ' ILE . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 57' ' ' ALA . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 57' ' ' ALA . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 75' ' ' LEU . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 29' ' ' VAL . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 HG12 ' A' ' 7' ' ' VAL . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' C ' HD12 ' A' ' 5' ' ' ILE . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 5' ' ' ILE . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 54' ' ' SER . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.501 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.46 ' HB ' HG23 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 57' ' ' ALA . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.736 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' ASP . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' ILE . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' ALA . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HE2' ' A' ' 82' ' ' LYS . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE2' HD11 ' A' ' 75' ' ' LEU . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 2' ' ' GLU . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 HG13 ' A' ' 44' ' ' VAL . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 5' ' ' ILE . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 57' ' ' ALA . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 57' ' ' ALA . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 75' ' ' LEU . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 29' ' ' VAL . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 HG12 ' A' ' 7' ' ' VAL . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.449 ' C ' HD12 ' A' ' 5' ' ' ILE . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 5' ' ' ILE . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 54' ' ' SER . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.501 ' HA ' ' OD1' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 45' ' ' LYS . 35.5 tt0 -153.29 144.54 23.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.03 161.6 36.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.115 1.766 . . . . 0.0 107.975 166.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.11 123.93 43.53 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.81 108.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.26 112.09 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.09 2.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.591 0.757 . . . . 0.0 111.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.9 ttp180 -62.83 163.5 9.36 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.696 2.398 . . . . 0.0 110.506 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.47 141.96 82.91 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.629 -0.67 . . . . 0.0 110.047 169.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.56 -19.06 42.88 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.111 2.54 . . . . 0.0 112.234 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.01 -38.91 84.03 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.825 -1.172 . . . . 0.0 113.192 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -82.38 -28.16 31.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.453 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 66.0 t80 -57.19 -35.5 69.68 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.769 -0.582 . . . . 0.0 110.669 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -73.89 1.03 11.58 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.513 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -111.88 -42.31 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -160.06 140.3 11.69 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.653 0.781 . . . . 0.0 108.91 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -151.97 162.71 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 110.151 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.6 t -66.33 134.82 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -58.03 108.3 0.58 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.638 1.175 . . . . 0.0 109.97 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.43 4.74 54.81 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.642 -1.088 . . . . 0.0 113.226 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.62 165.3 22.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.003 1.402 . . . . 0.0 110.824 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.73 154.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 169.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 17.9 t-20 -111.02 131.52 54.98 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 161.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.46 ' HB ' HG23 ' A' ' 29' ' ' VAL . 24.3 mt -146.45 109.96 4.21 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 169.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.98 150.95 84.32 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.828 1.685 . . . . 0.0 109.689 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 57' ' ' ALA . 44.7 tp -49.45 -42.53 43.26 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.037 0.923 . . . . 0.0 113.017 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -67.76 -30.02 69.37 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.439 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.06 -37.09 34.6 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.25 0.932 . . . . 0.0 109.662 171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -54.48 -38.51 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.595 1.089 . . . . 0.0 111.289 -172.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -65.1 -7.13 10.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -119.35 -49.67 2.37 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.435 1.112 . . . . 0.0 109.187 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -73.93 -20.48 60.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.247 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.39 -35.33 57.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.055 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.81 -28.15 68.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.433 1.015 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -86.83 -35.63 18.96 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.986 0.914 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.63 25.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.063 0.545 . . . . 0.0 112.438 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.32 66.29 12.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.436 1.894 . . . . 0.0 107.377 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.56 -27.01 61.61 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 121.512 1.475 . . . . 0.0 111.928 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -73.71 100.89 3.52 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.658 1.183 . . . . 0.0 109.713 172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -60.87 -15.81 34.65 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.39 -6.46 58.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 124.232 0.958 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -66.14 140.93 58.24 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.806 -1.183 . . . . 0.0 110.243 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 38.6 m -71.97 91.97 1.25 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.559 0.618 . . . . 0.0 110.76 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.21 101.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 2' ' ' GLU . 71.9 mttt -81.21 123.63 28.62 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.53 137.05 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -144.81 163.84 32.86 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.928 0.491 . . . . 0.0 111.167 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 13.6 p -147.83 -151.71 0.4 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.37 -46.06 81.62 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.807 -1.183 . . . . 0.0 110.554 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 -18.05 1.44 Allowed 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.13 -26.63 4.69 Favored Glycine 0 C--O 1.223 -0.58 0 CA-C-N 120.09 1.314 . . . . 0.0 112.018 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.6 -39.63 77.14 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.585 -0.95 . . . . 0.0 112.645 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -78.58 -34.59 46.79 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -69.14 -29.84 67.95 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.667 -0.646 . . . . 0.0 112.043 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.79 -49.0 71.45 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.736 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -59.76 -43.3 94.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.91 174.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -60.52 -39.13 86.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.973 -0.537 . . . . 0.0 111.671 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -58.11 -46.26 85.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.829 0.741 . . . . 0.0 109.2 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.4 -45.48 79.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.459 0.475 . . . . 0.0 109.901 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 mt -56.79 -47.5 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.137 0.975 . . . . 0.0 109.223 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.3 -35.27 68.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.22 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.2 m -59.61 -39.79 85.39 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.98 -36.94 84.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 52.4 mtp -68.74 -3.04 10.79 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.447 0.699 . . . . 0.0 112.87 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.34 62.48 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.182 171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.73 125.89 27.26 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 119.069 1.434 . . . . 0.0 107.972 167.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 p -91.57 -8.89 46.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.697 0.799 . . . . 0.0 111.918 -167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -137.17 48.15 2.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.449 1.499 . . . . 0.0 110.734 -173.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.74 146.85 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 O-C-N 118.613 -2.554 . . . . 0.0 107.917 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.55 139.11 41.96 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.81 124.69 34.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.1 35.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.708 0.803 . . . . 0.0 112.189 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.29 -132.08 10.92 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.01 161.59 25.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' HE2' ' A' ' 82' ' ' LYS . 3.1 tp -55.32 -26.72 42.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -164.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.269 11.8 mttt -75.99 -29.75 58.31 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.381 1.072 . . . . 0.0 113.744 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -96.58 -28.26 14.45 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 125.401 1.688 . . . . 0.0 108.042 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.47 124.54 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.25 44.31 1.45 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.851 0.834 . . . . 0.0 109.457 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mmm -96.98 158.95 32.53 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 124.606 1.163 . . . . 0.0 108.216 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.82 150.35 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.28 2.653 . . . . 0.0 111.644 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -130.03 162.35 28.91 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -168.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -129.95 152.64 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -139.89 164.53 29.74 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 123.595 0.559 . . . . 0.0 110.846 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.338 0 O-C-N 128.23 3.456 . . . . 0.0 113.185 -170.254 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -155.06 146.17 22.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.724 1.21 . . . . 0.0 108.579 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -141.16 166.66 24.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.147 2.179 . . . . 0.0 106.905 168.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -132.97 129.29 38.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 mm -128.85 110.89 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . 16.5 t0 -81.0 91.08 6.01 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.542 1.537 . . . . 0.0 107.082 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -72.33 -3.82 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.742 1.217 . . . . 0.0 112.51 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -65.83 161.32 21.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.502 2.321 . . . . 0.0 110.866 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.92 147.14 74.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.295 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.74 -20.77 22.44 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.448 2.099 . . . . 0.0 112.701 -170.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.55 -39.99 93.07 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.288 -0.882 . . . . 0.0 110.641 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -79.22 -27.64 42.5 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.857 -0.527 . . . . 0.0 110.934 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.618 -0.676 . . . . 0.0 110.369 169.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -78.64 22.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.552 1.141 . . . . 0.0 112.056 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.64 -38.16 0.74 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.457 1.503 . . . . 0.0 110.356 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -157.34 146.99 20.37 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.113 0.965 . . . . 0.0 109.232 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -155.53 155.17 32.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.956 1.702 . . . . 0.0 107.493 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -71.25 142.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -77.34 43.74 0.39 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.12 44.89 0.05 OUTLIER Glycine 0 CA--C 1.526 0.725 0 O-C-N 121.033 -1.042 . . . . 0.0 111.736 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.96 178.49 7.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.073 1.349 . . . . 0.0 110.231 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.81 137.02 58.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' ASP . 26.5 t-20 -91.2 125.5 35.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.76 118.89 5.69 Favored Pre-proline 0 N--CA 1.445 -0.693 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.02 147.31 84.33 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 121.226 1.474 . . . . 0.0 108.851 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.8 -36.64 48.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -58.29 -41.6 84.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.918 0.887 . . . . 0.0 111.142 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.72 -43.14 63.36 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.392 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.59 -44.05 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.27 0.941 . . . . 0.0 110.7 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -64.48 -5.55 5.63 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -121.5 -50.1 2.11 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.894 168.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.0 -24.98 67.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.242 1.417 . . . . 0.0 112.787 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.68 -34.33 42.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-N 119.738 1.153 . . . . 0.0 109.472 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -17.83 59.33 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.3 0.955 . . . . 0.0 113.447 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -101.9 -34.29 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.108 0.963 . . . . 0.0 110.186 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.16 64.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.145 0.578 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -143.38 79.27 14.13 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 127.697 2.399 . . . . 0.0 106.278 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.74 -24.0 47.85 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.755 1.636 . . . . 0.0 111.26 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.43 173.52 1.57 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 110.506 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -135.26 -24.07 1.44 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.837 -1.165 . . . . 0.0 111.878 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.11 -18.37 22.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.915 1.286 . . . . 0.0 111.113 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.73 123.92 18.91 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 m -65.67 100.08 0.5 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.007 1.323 . . . . 0.0 109.993 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.36 117.42 21.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -98.27 98.64 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -81.11 136.65 22.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -148.04 160.44 42.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.193 0.451 . . . . 0.0 111.477 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.8 p -158.17 177.79 10.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.604 2.761 . . . . 0.0 105.867 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -76.02 -38.31 57.43 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.231 -0.918 . . . . 0.0 111.753 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -17.17 58.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.75 -43.05 1.85 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.932 1.253 . . . . 0.0 112.404 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -48.06 -52.27 20.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.905 1.682 . . . . 0.0 112.836 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -68.97 -35.64 76.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.078 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -68.97 -28.9 67.04 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.0 0.818 . . . . 0.0 112.313 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -52.67 49.99 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -58.8 -42.11 88.34 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.572 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.36 80.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.998 0.817 . . . . 0.0 112.206 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.31 -43.46 98.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.341 0.973 . . . . 0.0 109.48 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.19 -47.96 72.22 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mt -56.64 -51.25 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.369 1.468 . . . . 0.0 110.282 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.59 -33.21 72.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.873 0.76 . . . . 0.0 110.891 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.8 m -62.31 -43.15 99.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.276 0.489 . . . . 0.0 110.065 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.16 -34.0 76.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.407 0.683 . . . . 0.0 111.643 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mtp -66.43 -16.29 63.98 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.271 0.628 . . . . 0.0 112.118 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.08 13.85 27.99 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.145 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -67.04 116.31 7.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.447 1.624 . . . . 0.0 107.088 170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.4 p -78.83 -14.07 59.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.91 1.284 . . . . 0.0 111.363 -172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.84 115.62 10.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.4 t -142.97 148.98 18.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -138.72 151.68 47.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 168.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.75 129.87 38.54 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.98 27.26 4.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 110.401 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.31 150.36 29.88 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.892 0.758 . . . . 0.0 113.384 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.2 100.88 1.92 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.184 1.849 . . . . 0.0 110.371 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.77 -34.47 59.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.147 0.979 . . . . 0.0 113.063 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -74.16 -27.24 60.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.4 -31.76 48.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.503 0.592 . . . . 0.0 111.119 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.07 -42.51 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.744 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.28 30.44 1.48 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.65 1.98 . . . . 0.0 114.513 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.3 mtp -86.77 163.29 41.75 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.962 0.905 . . . . 0.0 108.907 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.23 153.12 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.005 2.47 . . . . 0.0 111.721 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -127.69 173.25 10.07 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.672 0.789 . . . . 0.0 110.872 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -132.39 142.49 42.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 167.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -139.7 159.81 41.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.827 0.74 . . . . 0.0 110.303 -172.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -169.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.584 0.23 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -154.78 147.15 23.96 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.386 1.075 . . . . 0.0 108.133 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.24 162.74 36.42 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.34 1.856 . . . . 0.0 107.228 168.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -123.7 123.51 40.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.59 107.13 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -66.48 123.44 20.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.2 3.12 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.618 0.767 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.2 ttp180 -61.87 163.51 7.49 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.919 1.688 . . . . 0.0 109.893 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -58.6 143.83 80.76 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.86 -21.45 24.69 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.546 2.164 . . . . 0.0 112.989 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.86 -36.63 79.64 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.882 0.765 . . . . 0.0 110.852 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -76.54 -29.64 56.78 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.888 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 63.3 t80 -59.2 -33.6 71.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.732 0.696 . . . . 0.0 111.108 171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -66.54 -24.21 66.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.564 0.62 . . . . 0.0 111.431 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -85.13 -48.06 9.53 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.722 0.692 . . . . 0.0 109.955 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.58 145.77 19.09 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.469 1.108 . . . . 0.0 109.033 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -151.19 160.48 43.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.508 1.123 . . . . 0.0 110.039 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.05 134.62 26.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -57.55 114.76 2.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.801 0.84 . . . . 0.0 110.159 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.14 -2.17 83.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.582 1.086 . . . . 0.0 114.483 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.54 152.83 43.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.566 1.683 . . . . 0.0 111.201 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.2 mm -82.65 163.63 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 10.5 t-20 -130.5 130.59 44.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 164.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.7 mt -142.78 114.49 6.01 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -63.17 152.86 77.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.376 1.384 . . . . 0.0 108.904 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tt -50.92 -40.71 57.72 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.612 0.765 . . . . 0.0 112.908 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -55.32 -26.2 39.22 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.568 1.147 . . . . 0.0 113.508 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -111.12 -26.99 8.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.036 1.334 . . . . 0.0 112.074 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.13 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.637 1.562 . . . . 0.0 110.166 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -58.33 -15.4 10.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.12 1.768 . . . . 0.0 113.99 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.51 -29.94 3.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.696 1.135 . . . . 0.0 112.537 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -80.8 -28.92 36.13 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.377 -0.827 . . . . 0.0 112.209 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tp -59.26 -32.25 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.427 1.012 . . . . 0.0 109.595 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.15 -19.3 53.1 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 m -107.12 -31.93 8.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.867 0.867 . . . . 0.0 110.237 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.38 -35.15 58.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.876 0.47 . . . . 0.0 111.539 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.0 72.78 14.8 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.369 1.868 . . . . 0.0 107.627 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.59 -22.2 58.56 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.252 1.968 . . . . 0.0 112.595 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.23 102.11 3.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.505 0.722 . . . . 0.0 109.965 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.6 -15.62 40.75 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.43 5.92 47.67 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.366 0.985 . . . . 0.0 110.928 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.63 145.55 56.0 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 120.697 -1.252 . . . . 0.0 108.883 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -75.22 80.7 2.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.888 0.375 . . . . 0.0 110.161 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.37 99.41 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -81.89 139.48 34.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.1 m -124.6 139.55 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -141.94 167.75 21.39 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.322 1.049 . . . . 0.0 108.92 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 32.1 p -153.13 -157.78 0.82 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.198 1.399 . . . . 0.0 107.895 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -75.64 -36.87 60.07 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.389 -0.819 . . . . 0.0 112.451 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.47 19.56 2.38 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.07 -32.13 2.01 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.635 1.112 . . . . 0.0 114.689 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -63.15 -43.44 98.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.464 1.632 . . . . 0.0 112.361 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -72.26 -39.39 68.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 p -68.9 -27.73 66.04 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 111.369 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.24 65.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -59.66 -42.42 92.79 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 118.967 -0.539 . . . . 0.0 110.544 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.0 91.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.046 0.839 . . . . 0.0 111.614 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -59.54 -44.66 93.15 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.575 1.08 . . . . 0.0 109.589 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -65.44 -47.72 75.2 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.2 mt -57.31 -50.4 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.085 1.354 . . . . 0.0 110.205 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -69.27 -33.58 73.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.434 0.561 . . . . 0.0 110.751 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.5 m -64.87 -40.46 95.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.998 -0.439 . . . . 0.0 110.596 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.03 -32.14 73.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 0.0 111.227 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.2 mtp -70.7 -1.59 11.87 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.271 1.028 . . . . 0.0 112.364 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 16.1 67.53 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.738 -1.035 . . . . 0.0 112.97 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.7 126.15 28.81 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 p -94.12 -7.46 42.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 113.413 -166.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.83 24.52 3.36 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.752 0.705 . . . . 0.0 112.304 -172.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.8 t -60.06 145.26 11.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.5 150.56 43.9 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -101.42 129.92 47.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.64 10.04 21.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.928 0.891 . . . . 0.0 111.724 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.03 -146.26 23.92 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.552 0.614 . . . . 0.0 112.272 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -110.44 148.08 17.53 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.29 -31.22 42.84 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.782 1.633 . . . . 0.0 114.154 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -67.53 -13.81 62.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -124.29 -2.03 8.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.299 0.954 . . . . 0.0 112.93 -168.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.13 -27.91 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.41 -0.806 . . . . 0.0 110.816 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.44 50.6 17.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.324 1.45 . . . . 0.0 111.893 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 76.1 mtp -134.81 160.46 68.34 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 126.11 1.764 . . . . 0.0 108.468 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.31 155.33 52.46 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.584 2.189 . . . . 0.0 111.819 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -127.13 175.5 8.08 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.336 1.055 . . . . 0.0 109.992 -170.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -136.03 144.11 34.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.83 156.09 48.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.721 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.331 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -153.59 147.61 25.57 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.638 1.175 . . . . 0.0 108.476 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -144.15 159.2 43.05 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 126.429 1.891 . . . . 0.0 107.244 168.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -117.24 117.87 30.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.0 mm -116.5 99.09 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.82 127.51 31.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.39 15.88 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.785 1.234 . . . . 0.0 110.907 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -74.94 166.62 23.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.946 1.699 . . . . 0.0 108.969 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.9 140.24 95.63 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.14 -23.64 28.85 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.308 2.005 . . . . 0.0 112.654 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.35 -42.53 96.18 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.387 -0.821 . . . . 0.0 110.064 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -72.48 -36.9 68.54 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.758 0.423 . . . . 0.0 110.673 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -57.6 -41.0 80.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.625 0.648 . . . . 0.0 110.944 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.71 -18.89 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.422 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -77.71 -45.22 25.44 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 120.021 1.282 . . . . 0.0 110.168 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -160.46 145.56 14.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.941 0.496 . . . . 0.0 110.801 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -154.38 166.49 33.06 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.781 1.233 . . . . 0.0 110.583 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.99 142.82 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.938 0.895 . . . . 0.0 108.948 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -74.47 48.05 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.45 1.9 . . . . 0.0 111.66 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.35 49.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.119 -0.988 . . . . 0.0 111.742 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.74 171.52 14.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.071 0.949 . . . . 0.0 111.37 -174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -121.62 155.31 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 105.62 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -111.47 127.97 55.86 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.83 98.39 6.34 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.41 152.84 64.56 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.964 1.776 . . . . 0.0 109.324 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.1 tp -52.38 -38.99 60.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -168.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -63.06 -32.15 73.45 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.305 -0.872 . . . . 0.0 112.607 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -84.76 -40.58 17.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.057 0.943 . . . . 0.0 110.932 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -36.02 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.242 0.928 . . . . 0.0 110.823 -169.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -63.04 -4.75 2.46 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.619 1.168 . . . . 0.0 114.151 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -127.45 -51.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.421 1.088 . . . . 0.0 109.014 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -66.07 -23.39 66.52 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.005 1.322 . . . . 0.0 112.856 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.01 -33.79 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 120.039 1.291 . . . . 0.0 109.973 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.71 83.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.856 0.753 . . . . 0.0 111.26 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -71.33 -43.17 67.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.103 0.961 . . . . 0.0 110.243 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.19 -33.66 32.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.411 0.684 . . . . 0.0 112.77 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.25 66.61 14.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.964 1.706 . . . . 0.0 109.004 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.37 -12.51 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.531 2.154 . . . . 0.0 113.403 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.89 -30.22 70.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.471 1.109 . . . . 0.0 113.868 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 58.38 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.563 2.745 . . . . 0.0 117.337 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -15.79 61.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.645 1.578 . . . . 0.0 111.126 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -58.22 142.62 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.198 0.599 . . . . 0.0 111.186 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 m -75.79 82.52 2.74 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.59 98.54 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -79.15 139.19 38.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.82 140.07 47.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 118.714 0.688 . . . . 0.0 109.644 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -149.25 170.9 17.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.091 0.956 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.3 t -158.49 -161.57 1.01 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.368 2.267 . . . . 0.0 106.307 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.56 -43.9 95.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.04 32.33 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.878 1.671 . . . . 0.0 109.012 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.87 -14.57 52.61 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 116.11 1.204 . . . . 0.0 116.11 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -57.52 -53.24 60.42 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.901 1.85 . . . . 0.0 112.233 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.09 -38.5 61.22 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.4 p -69.84 -29.76 67.09 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.142 -0.349 . . . . 0.0 110.86 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.93 -46.29 75.19 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -60.75 -39.99 90.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.239 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -63.19 -40.44 97.51 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.804 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -59.04 -44.38 91.76 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.134 0.879 . . . . 0.0 109.457 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -67.39 -46.62 72.71 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.148 0.979 . . . . 0.0 108.608 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.8 mt -55.57 -49.8 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.152 0.981 . . . . 0.0 110.453 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.95 -31.54 68.15 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 121.705 -0.622 . . . . 0.0 111.005 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -63.61 -40.77 97.75 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.097 0.408 . . . . 0.0 110.188 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.45 -32.46 73.84 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.019 0.827 . . . . 0.0 111.407 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.4 mtp -70.3 -3.51 17.61 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.695 0.798 . . . . 0.0 112.504 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.53 14.27 61.9 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.74 -1.034 . . . . 0.0 113.024 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -68.61 131.43 45.21 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.8 p -100.42 -2.1 34.21 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.335 0.654 . . . . 0.0 112.753 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.07 25.74 2.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.399 0.619 . . . . 0.0 111.863 -170.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -62.58 145.26 13.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.66 147.19 42.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -99.17 125.79 44.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.42 12.95 29.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.448 0.699 . . . . 0.0 111.378 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.3 -116.85 6.02 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.32 165.26 28.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -52.39 -39.93 61.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.685 1.194 . . . . 0.0 112.9 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -62.03 -39.02 90.89 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.726 0.81 . . . . 0.0 111.456 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.98 -35.08 57.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.802 0.441 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.76 -48.17 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.625 0.77 . . . . 0.0 109.705 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.6 32.37 1.14 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.168 1.787 . . . . 0.0 114.676 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 84.7 mtp -74.55 168.86 23.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.209 1.004 . . . . 0.0 109.363 169.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.65 147.52 6.73 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.006 2.471 . . . . 0.0 111.632 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -120.61 172.76 7.63 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.57 0.7 . . . . 0.0 111.468 -168.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.3 140.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 102.28 -3.23 . . . . 0.0 102.28 165.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -128.96 153.97 47.03 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.056 0.942 . . . . 0.0 109.244 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 171.612 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.46 146.83 21.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.007 1.323 . . . . 0.0 108.529 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -141.72 165.47 27.4 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.556 1.942 . . . . 0.0 107.141 168.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' ILE . 39.4 m95 -128.21 116.57 20.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.5 mp -121.44 112.79 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.24 125.46 26.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.25 0.78 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.407 0.683 . . . . 0.0 111.84 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.1 ttp180 -59.9 163.81 4.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.281 1.432 . . . . 0.0 110.33 172.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 m -58.76 143.76 81.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.95 -18.96 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.791 2.327 . . . . 0.0 112.898 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.36 -36.9 81.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -80.34 -30.18 38.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.869 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 70.1 t80 -57.21 -38.68 74.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.683 0.674 . . . . 0.0 110.962 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -69.57 -10.35 57.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.506 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -96.75 -45.58 6.61 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.569 1.077 . . . . 0.0 110.221 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.56 142.74 18.16 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.627 1.171 . . . . 0.0 108.573 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -152.06 159.05 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.142 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 134.78 28.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -52.51 122.37 8.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 110.442 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.37 79.48 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.647 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.87 46.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.606 1.703 . . . . 0.0 110.659 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.08 168.38 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.7 t-20 -128.32 128.31 44.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.0 mt -141.34 108.15 6.17 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.51 152.71 78.91 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.47 1.447 . . . . 0.0 109.212 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' ALA . 25.2 tp -51.17 -39.71 57.02 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -60.5 -32.51 71.5 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -87.07 -44.08 11.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.658 0.783 . . . . 0.0 110.508 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -35.47 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 122.99 0.516 . . . . 0.0 111.45 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -60.46 -14.2 18.0 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.79 -45.24 2.79 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.966 0.803 . . . . 0.0 109.506 169.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -67.29 -26.31 66.47 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.113 0.965 . . . . 0.0 112.871 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.13 -33.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.632 1.106 . . . . 0.0 109.822 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.79 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -109.42 -31.33 7.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.157 0.983 . . . . 0.0 110.229 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.78 -34.18 58.0 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.15 0.58 . . . . 0.0 111.652 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -144.34 72.97 16.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.225 2.21 . . . . 0.0 106.244 -174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -64.53 -36.56 42.58 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.401 1.401 . . . . 0.0 111.116 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -70.91 118.1 13.25 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.832 0.853 . . . . 0.0 109.659 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -70.62 -15.51 62.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.34 -172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -8.39 28.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.206 0.912 . . . . 0.0 112.71 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.32 123.77 21.28 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.8 m -61.59 104.86 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.345 1.058 . . . . 0.0 108.9 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.95 95.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -69.12 134.87 49.9 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.69 138.2 55.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -142.53 164.82 29.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.394 1.078 . . . . 0.0 108.591 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.5 p -148.26 -156.78 0.75 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.673 1.589 . . . . 0.0 106.976 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -72.14 -45.05 62.05 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.009 1.277 . . . . 0.0 112.523 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 -9.82 2.74 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.47 -27.94 6.15 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.314 0.959 . . . . 0.0 114.149 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -66.85 -44.4 81.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.379 1.59 . . . . 0.0 112.075 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -69.38 -38.28 77.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.758 0.423 . . . . 0.0 109.878 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.9 p -72.89 -28.53 62.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.785 0.72 . . . . 0.0 111.375 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.67 72.34 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -60.53 -44.23 96.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.376 172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.66 -40.48 79.42 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.832 0.742 . . . . 0.0 111.775 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.0 -50.08 73.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.829 0.74 . . . . 0.0 109.055 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.98 -39.41 72.5 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.1 mt -55.03 -53.06 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.672 1.189 . . . . 0.0 109.469 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.65 -35.01 76.7 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.589 0.632 . . . . 0.0 111.194 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.9 m -63.57 -44.82 93.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -67.46 -32.18 72.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.705 0.802 . . . . 0.0 111.235 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.0 mtp -66.79 -14.83 63.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.314 0.646 . . . . 0.0 112.248 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.29 11.83 30.61 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.508 -1.162 . . . . 0.0 113.282 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.83 119.09 10.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.586 1.693 . . . . 0.0 107.332 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -79.21 -15.9 57.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.945 0.898 . . . . 0.0 111.013 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -134.16 117.33 16.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -142.06 146.94 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -143.91 127.59 17.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -82.0 109.78 16.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.97 58.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.228 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.4 -144.41 16.11 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.81 150.42 17.29 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.5 tp -60.09 -30.25 69.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.318 1.047 . . . . 0.0 112.595 -169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -66.29 -25.66 66.96 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.46 -32.91 12.66 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 110.906 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.53 130.81 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.33 24.59 8.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.574 1.149 . . . . 0.0 111.723 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 88.6 mtp -70.42 162.47 70.02 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.076 0.95 . . . . 0.0 109.124 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.05 134.73 18.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.48 2.787 . . . . 0.0 112.322 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -111.51 162.53 15.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.589 0.756 . . . . 0.0 109.548 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.6 t -128.33 144.26 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 103.245 -2.872 . . . . 0.0 103.245 167.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -137.7 166.85 22.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.824 0.85 . . . . 0.0 109.965 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -150.96 148.0 27.86 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -144.02 162.37 36.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.433 1.893 . . . . 0.0 107.095 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -125.32 125.8 44.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -123.63 107.86 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.94 98.24 2.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -77.27 5.33 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 125.215 1.406 . . . . 0.0 112.336 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -72.2 164.68 25.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.762 2.425 . . . . 0.0 110.939 -173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -57.03 141.34 76.39 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 166.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.99 -29.62 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.209 1.94 . . . . 0.0 113.697 -168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -64.14 -40.49 96.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.843 1.201 . . . . 0.0 110.766 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.18 -15.45 61.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.158 -0.925 . . . . 0.0 112.053 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -58.96 -32.3 69.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.58 1.537 . . . . 0.0 110.883 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.45 -29.39 69.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.941 0.896 . . . . 0.0 111.745 176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -76.08 -45.2 35.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.124 0.57 . . . . 0.0 110.652 -169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -161.15 136.54 7.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -154.63 157.69 38.57 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 119.178 0.899 . . . . 0.0 110.88 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.1 139.99 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.294 1.038 . . . . 0.0 108.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -58.16 134.54 56.57 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.394 0.678 . . . . 0.0 110.1 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.02 3.6 75.46 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.342 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.1 175.82 5.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.925 1.362 . . . . 0.0 111.767 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mm -121.23 151.97 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.71 131.73 55.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.9 mt -146.22 123.95 6.16 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.42 146.42 85.37 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.091 1.425 . . . . 0.0 109.12 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.7 tp -51.83 -35.56 44.89 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -57.37 -44.29 84.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.825 0.85 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -74.57 -38.53 62.66 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.79 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.3 t -49.65 -42.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.411 1.005 . . . . 0.0 110.5 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -65.41 -2.96 3.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.88 -50.98 1.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.546 1.138 . . . . 0.0 108.177 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -66.82 -22.82 66.0 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.169 1.388 . . . . 0.0 112.982 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.15 -34.43 53.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 119.768 1.167 . . . . 0.0 109.63 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.71 80.89 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.465 1.03 . . . . 0.0 111.607 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 m -72.65 -43.99 62.45 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.202 1.001 . . . . 0.0 110.365 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 -32.47 32.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.656 0.782 . . . . 0.0 112.348 -171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.96 71.59 16.78 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.896 2.078 . . . . 0.0 107.64 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.22 -24.31 58.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.166 1.911 . . . . 0.0 112.143 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.67 99.97 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.611 0.764 . . . . 0.0 110.126 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.29 -15.9 29.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.93 7.16 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.349 0.977 . . . . 0.0 111.307 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.57 146.23 54.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.501 -1.374 . . . . 0.0 109.851 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -78.2 81.42 4.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.115 0.483 . . . . 0.0 110.12 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.32 123.18 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -107.38 103.47 12.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -84.02 138.26 19.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.5 172.5 15.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.689 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.1 t -167.73 162.22 13.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.845 2.458 . . . . 0.0 105.843 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.8 -14.47 61.45 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.196 -0.94 . . . . 0.0 112.329 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 104.24 7.29 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.031 1.732 . . . . 0.0 107.076 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.35 -21.46 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.431 1.015 . . . . 0.0 114.434 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -49.31 -48.55 46.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.377 1.088 . . . . 0.0 112.125 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -80.18 -22.25 42.12 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.322 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -62.16 -41.77 98.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.024 1.284 . . . . 0.0 109.779 167.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -49.72 64.01 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -58.86 -38.82 79.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.72 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.18 83.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.165 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -59.58 -43.95 93.49 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.621 1.101 . . . . 0.0 109.233 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.01 -41.64 77.47 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.39 -51.29 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.256 1.023 . . . . 0.0 110.337 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -70.76 -32.19 69.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.093 0.861 . . . . 0.0 110.802 -175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -63.64 -40.16 96.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.036 0.38 . . . . 0.0 110.125 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.03 -35.3 80.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.259 1.023 . . . . 0.0 111.062 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.25 -7.6 31.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.794 0.838 . . . . 0.0 112.507 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.36 60.89 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.119 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -66.15 137.04 56.74 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.336 1.568 . . . . 0.0 107.213 169.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 p -104.24 -15.24 15.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -168.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -122.9 28.51 7.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.315 1.046 . . . . 0.0 110.609 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.6 t -62.95 134.73 28.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -134.24 144.87 48.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.715 0.769 . . . . 0.0 109.895 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -95.64 108.17 20.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.68 -38.31 62.43 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.457 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.63 -151.55 18.58 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.75 143.57 16.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HE2' ' A' ' 82' ' ' LYS . 21.0 tp -60.6 -28.55 68.6 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.64 -31.29 71.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.999 0.52 . . . . 0.0 111.287 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.89 -32.54 20.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.439 0.696 . . . . 0.0 111.164 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.78 135.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.97 0.908 . . . . 0.0 108.982 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.18 87.04 2.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.5 tpt -148.61 147.41 24.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.544 1.938 . . . . 0.0 106.016 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.34 137.4 24.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.341 2.694 . . . . 0.0 112.483 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE2' HD11 ' A' ' 75' ' ' LEU . 38.3 mttt -128.57 167.81 16.61 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.199 1.0 . . . . 0.0 111.824 -168.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.29 146.03 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -142.06 167.43 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.312 0.645 . . . . 0.0 109.74 -173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 32.0 tt0 -151.2 141.2 22.07 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.054 -1.028 . . . . 0.0 109.367 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.91 158.58 44.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.915 2.086 . . . . 0.0 106.28 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -122.26 131.33 53.87 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mm -128.4 106.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -70.99 113.56 8.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.12 3.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.093 0.957 . . . . 0.0 111.54 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.8 ttp180 -65.23 171.12 4.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.295 2.238 . . . . 0.0 109.871 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.88 141.85 98.05 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.71 -19.58 36.16 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.74 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.02 -29.71 69.87 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.443 -0.785 . . . . 0.0 111.33 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -91.12 -28.31 17.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.476 0.58 . . . . 0.0 111.039 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.18 -40.77 78.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.834 0.743 . . . . 0.0 110.343 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.23 1.29 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.551 1.14 . . . . 0.0 113.225 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -119.51 -36.85 3.25 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.419 1.087 . . . . 0.0 110.844 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -157.29 133.2 9.43 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -151.79 155.61 38.56 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.901 0.88 . . . . 0.0 109.871 171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.45 135.06 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -57.56 126.74 28.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.404 0.682 . . . . 0.0 109.405 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.24 5.3 89.75 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.272 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.51 179.83 2.38 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.027 1.414 . . . . 0.0 111.884 173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.41 142.53 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 169.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -90.96 119.48 31.18 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 168.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 mt -142.92 90.13 7.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.16 153.97 49.01 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.302 2.001 . . . . 0.0 109.248 -174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 57' ' ' ALA . 22.4 tp -51.04 -39.11 55.13 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -168.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -62.29 -33.89 75.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.589 0.756 . . . . 0.0 112.802 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.16 -43.75 17.33 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.425 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.74 -36.48 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 119.284 0.947 . . . . 0.0 111.884 -167.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -59.96 -15.13 19.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.424 1.09 . . . . 0.0 113.736 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -122.34 -46.69 2.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.087 0.955 . . . . 0.0 109.719 171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -66.27 -26.06 67.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.133 0.973 . . . . 0.0 112.305 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -59.2 -34.7 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.923 1.238 . . . . 0.0 109.975 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -19.91 62.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -99.27 -35.51 9.94 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.78 0.832 . . . . 0.0 110.232 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.45 -33.55 48.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.254 0.621 . . . . 0.0 112.158 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.12 71.64 22.89 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.642 1.977 . . . . 0.0 106.766 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.17 -28.69 40.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.114 1.876 . . . . 0.0 112.032 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -78.78 104.31 9.32 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -59.85 -18.38 43.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -84.7 -12.64 53.42 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.998 0.817 . . . . 0.0 112.63 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.59 136.91 58.12 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 2' ' ' GLU . 18.6 m -66.09 133.6 51.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.936 0.789 . . . . 0.0 109.027 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 t -118.11 90.46 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -81.19 85.43 6.35 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.74 138.14 21.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -146.19 161.33 40.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.68 0.792 . . . . 0.0 111.604 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 26.9 p -150.88 -157.73 0.84 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.604 1.562 . . . . 0.0 108.996 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.27 -49.69 58.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.676 0.671 . . . . 0.0 111.418 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.66 -2.42 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -168.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.16 22.91 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.154 0.883 . . . . 0.0 113.741 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -67.33 -45.72 75.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.409 1.604 . . . . 0.0 112.184 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -73.51 -34.48 65.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.167 0.439 . . . . 0.0 110.008 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 p -72.09 -28.07 63.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.718 0.69 . . . . 0.0 111.444 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.55 68.07 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -59.81 -42.85 94.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.543 172.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.325 0.966 . . . . 0.0 112.075 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -57.68 -47.42 82.36 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.112 0.869 . . . . 0.0 109.06 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -73.61 -39.02 64.88 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.7 mt -58.38 -46.6 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.453 1.101 . . . . 0.0 109.463 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 34.2 mt -74.63 -24.04 58.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.373 -0.83 . . . . 0.0 111.593 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.7 m -65.78 -40.03 91.58 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.929 0.786 . . . . 0.0 110.053 169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -67.71 -30.92 70.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.847 0.749 . . . . 0.0 110.972 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 83.0 mmm -70.68 -5.49 30.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.593 0.757 . . . . 0.0 112.059 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.73 78.56 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.053 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -65.04 126.59 28.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.479 1.639 . . . . 0.0 108.047 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.6 p -87.99 -7.56 56.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.7 0.8 . . . . 0.0 112.403 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.24 36.96 1.71 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.775 0.797 . . . . 0.0 111.571 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.9 m -58.57 151.29 4.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 120.909 -1.119 . . . . 0.0 108.82 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.39 125.54 12.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -80.39 107.06 12.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.33 -39.82 62.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.272 -0.394 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -147.07 17.22 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.99 147.9 17.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.2 -29.69 67.67 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -169.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -66.76 -40.81 88.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.016 0.526 . . . . 0.0 110.873 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.6 -34.08 53.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.116 0.566 . . . . 0.0 111.176 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.98 -43.88 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.044 0.937 . . . . 0.0 110.507 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.73 33.26 1.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.104 1.762 . . . . 0.0 114.683 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 79.7 mmm -72.34 164.65 57.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.988 0.915 . . . . 0.0 109.661 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.31 141.8 23.6 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.222 2.615 . . . . 0.0 110.963 168.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -132.05 161.4 33.3 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.482 0.713 . . . . 0.0 111.622 -168.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.22 145.54 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 168.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -141.39 169.65 17.2 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.566 0.746 . . . . 0.0 110.332 -168.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.9 158.64 28.56 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.563 -0.71 . . . . 0.0 111.86 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -141.08 160.38 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.054 2.142 . . . . 0.0 107.526 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -115.71 126.17 53.75 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mm -126.83 107.38 16.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.17 108.22 5.23 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.702 1.201 . . . . 0.0 108.191 171.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.76 -1.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.301 1.04 . . . . 0.0 112.072 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.0 ttp180 -61.51 163.84 6.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.701 2.0 . . . . 0.0 110.744 174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 m -60.64 143.62 90.29 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.554 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.64 -18.82 32.6 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.651 2.234 . . . . 0.0 112.092 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.61 -22.37 63.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.254 1.022 . . . . 0.0 111.769 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -99.27 -26.0 14.31 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.533 -0.73 . . . . 0.0 111.655 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 90.8 t80 -53.86 -42.58 68.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.233 0.924 . . . . 0.0 112.059 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -63.68 -17.31 62.83 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -98.52 -33.03 11.16 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.217 1.007 . . . . 0.0 110.777 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -165.27 137.61 4.3 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.495 1.118 . . . . 0.0 108.985 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -158.6 159.14 35.11 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.919 1.288 . . . . 0.0 109.436 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.4 137.59 24.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -55.87 123.9 15.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.333 0.653 . . . . 0.0 109.26 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.38 -1.29 88.52 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.845 -0.975 . . . . 0.0 114.4 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.67 168.46 16.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.255 1.527 . . . . 0.0 111.657 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mm -108.29 157.07 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 11.3 t-20 -116.7 129.82 56.36 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 166.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.08 101.47 4.47 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 103.064 -2.939 . . . . 0.0 103.064 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.87 153.15 77.33 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.469 1.446 . . . . 0.0 109.106 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -42.42 -54.17 3.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -62.29 -30.55 71.22 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.393 -0.817 . . . . 0.0 112.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.41 -35.33 40.79 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.761 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -37.52 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.838 1.199 . . . . 0.0 110.402 -173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -64.64 -3.06 2.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.17 -51.6 1.88 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.467 1.03 . . . . 0.0 109.6 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -65.36 -22.82 66.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.475 1.11 . . . . 0.0 113.39 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.5 tp -60.19 -32.95 51.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.766 1.166 . . . . 0.0 109.925 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.53 80.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.972 0.805 . . . . 0.0 111.171 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -72.89 -42.8 63.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.923 0.889 . . . . 0.0 110.286 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.25 -32.57 26.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.594 0.758 . . . . 0.0 112.776 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -142.94 59.5 8.09 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.973 1.709 . . . . 0.0 109.009 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.59 -18.78 63.9 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.248 1.965 . . . . 0.0 112.679 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.16 -30.3 71.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.517 1.527 . . . . 0.0 113.435 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 57.82 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -86.52 -30.12 22.19 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.664 1.574 . . . . 0.0 110.865 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.65 130.42 28.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.639 1.176 . . . . 0.0 108.415 168.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.1 m -60.96 147.87 41.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.161 0.984 . . . . 0.0 109.585 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -128.82 103.45 9.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -84.23 93.91 8.29 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.3 135.64 25.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -147.96 167.04 25.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.822 0.449 . . . . 0.0 111.538 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.3 p -150.65 -145.18 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.661 1.584 . . . . 0.0 108.938 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.11 -45.55 80.75 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.585 -0.697 . . . . 0.0 110.841 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.53 -23.95 0.59 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.01 -23.6 1.14 Allowed Glycine 0 C--N 1.342 0.902 0 CA-C-N 120.003 1.274 . . . . 0.0 115.122 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -53.25 -58.64 6.37 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.893 1.346 . . . . 0.0 111.872 -172.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.99 -28.44 62.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.502 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -39.61 82.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.339 1.056 . . . . 0.0 111.162 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -48.33 78.96 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -63.05 -40.87 98.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.436 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.8 91.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.928 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -58.65 -47.38 84.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.848 0.749 . . . . 0.0 109.344 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.26 -35.55 68.8 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.3 mt -59.4 -47.77 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.081 0.953 . . . . 0.0 110.572 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.49 -28.26 61.83 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.195 -0.941 . . . . 0.0 111.022 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -65.36 -41.05 94.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 172.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.83 -36.84 84.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.26 1.024 . . . . 0.0 110.69 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -69.59 -3.86 16.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.486 1.114 . . . . 0.0 112.944 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.42 15.34 69.03 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.432 1.015 . . . . 0.0 113.65 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -68.35 138.53 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -101.87 -7.95 22.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -169.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -134.32 39.78 3.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.895 1.278 . . . . 0.0 109.738 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 t -62.06 139.47 20.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.49 125.75 20.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -75.8 131.69 39.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.88 24.36 8.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.23 0.612 . . . . 0.0 111.87 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.43 -126.13 32.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.56 172.82 38.72 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 117.819 0.81 . . . . 0.0 111.509 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.9 mt -55.73 -27.27 49.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -89.1 10.22 22.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.824 0.738 . . . . 0.0 112.283 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -129.9 -29.61 2.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.801 1.641 . . . . 0.0 111.267 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.38 147.53 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.104 1.362 . . . . 0.0 108.971 170.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.22 60.38 1.7 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.678 1.591 . . . . 0.0 108.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 87.1 mtp -139.7 161.83 54.31 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.409 1.883 . . . . 0.0 108.624 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.2 151.2 75.01 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.67 2.247 . . . . 0.0 112.367 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -130.72 161.73 31.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 125.002 1.321 . . . . 0.0 109.98 -170.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -126.91 142.56 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -143.49 162.15 36.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.62 0.768 . . . . 0.0 109.924 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 173.04 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.522 0.201 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.38 147.74 24.98 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -144.08 162.3 36.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.239 1.815 . . . . 0.0 107.061 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -124.09 120.01 31.14 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 HG13 ' A' ' 44' ' ' VAL . 1.7 mp -121.43 115.13 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -70.48 114.96 9.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.96 0.36 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.378 0.671 . . . . 0.0 111.797 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.6 ttp180 -63.25 166.02 6.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.418 2.287 . . . . 0.0 110.471 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -59.66 143.42 86.67 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.459 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.52 -18.83 25.48 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.863 2.375 . . . . 0.0 112.699 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.48 -32.99 70.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.076 0.95 . . . . 0.0 111.053 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -87.9 -27.03 22.43 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.588 -0.695 . . . . 0.0 111.545 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 72.9 t80 -56.02 -38.77 70.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.16 0.891 . . . . 0.0 110.541 170.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.03 11.81 0.64 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.781 1.232 . . . . 0.0 112.757 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -130.23 -41.34 1.26 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.964 1.306 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.07 142.37 19.47 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.393 1.077 . . . . 0.0 108.415 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -154.75 162.23 41.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.601 1.16 . . . . 0.0 109.956 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.4 136.45 26.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -51.95 124.7 13.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.253 1.021 . . . . 0.0 110.598 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.97 -2.2 61.05 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.701 -1.055 . . . . 0.0 114.484 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.15 149.72 47.26 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.466 1.633 . . . . 0.0 110.445 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 166.26 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 168.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t-20 -124.48 128.89 49.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.4 mt -142.19 111.12 6.01 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.548 -3.13 . . . . 0.0 102.548 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.35 151.44 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.623 1.549 . . . . 0.0 108.907 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.2 tp -50.02 -40.53 45.03 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.43 -41.45 80.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.86 0.864 . . . . 0.0 111.327 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -79.83 -44.62 20.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.334 -0.841 . . . . 0.0 111.039 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.53 -38.6 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.012 0.824 . . . . 0.0 111.744 -167.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -54.04 -35.68 62.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.086 0.554 . . . . 0.0 112.168 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.04 -45.48 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.151 0.887 . . . . 0.0 109.662 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.43 -26.03 63.48 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.605 1.162 . . . . 0.0 112.972 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tp -58.82 -33.02 48.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-N 119.608 1.095 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.17 68.6 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.789 0.722 . . . . 0.0 112.518 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -86.21 -40.23 15.8 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.098 0.959 . . . . 0.0 110.098 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.41 56.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.42 0.688 . . . . 0.0 112.186 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.19 75.21 17.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.786 2.034 . . . . 0.0 107.049 -174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.38 -31.81 92.18 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.432 2.088 . . . . 0.0 112.985 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -71.26 100.34 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.059 0.944 . . . . 0.0 110.182 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.21 -15.7 48.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.73 5.89 48.65 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.292 0.951 . . . . 0.0 110.957 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.06 146.29 55.2 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 120.672 -1.267 . . . . 0.0 108.942 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 m -75.09 82.59 2.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.467 HG13 HD13 ' A' ' 5' ' ' ILE . 25.6 t -72.31 94.21 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -72.26 139.1 47.9 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -127.33 136.01 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.03 166.94 24.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.945 0.898 . . . . 0.0 110.587 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.7 p -152.43 -156.44 0.7 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.909 2.083 . . . . 0.0 107.187 172.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -76.43 -62.92 1.46 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.261 0.937 . . . . 0.0 109.475 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.49 -20.21 21.98 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -18.03 41.83 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.66 1.124 . . . . 0.0 113.233 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -67.18 -42.03 84.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.935 1.367 . . . . 0.0 112.303 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.88 -37.39 70.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.436 0.562 . . . . 0.0 109.826 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -68.02 -32.37 72.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.603 0.638 . . . . 0.0 111.59 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.43 67.8 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -63.09 -39.64 95.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.098 0.449 . . . . 0.0 110.654 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.59 88.61 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.839 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -56.98 -45.37 82.99 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.948 0.795 . . . . 0.0 109.544 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -73.02 -38.35 66.59 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.4 mt -56.73 -49.4 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.752 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.53 -28.67 64.04 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.48 -0.762 . . . . 0.0 111.536 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.4 m -65.26 -41.08 94.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.199 0.454 . . . . 0.0 110.1 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -68.09 -31.95 71.93 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.512 -0.742 . . . . 0.0 111.309 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mmm -67.34 -8.14 30.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.175 0.99 . . . . 0.0 112.189 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.53 70.16 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.563 -1.132 . . . . 0.0 112.903 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -66.83 131.44 45.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.405 1.603 . . . . 0.0 106.954 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.6 p -98.46 -5.89 31.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 112.649 -168.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.86 28.0 2.94 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.384 0.674 . . . . 0.0 111.646 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.8 141.3 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -140.26 122.99 16.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.45 131.02 39.86 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.08 15.38 22.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.584 0.754 . . . . 0.0 111.556 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 -131.64 18.48 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.88 169.13 31.87 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 mt -54.47 -25.54 25.91 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.603 1.161 . . . . 0.0 113.594 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -19.8 64.89 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -130.03 -16.03 3.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.344 1.057 . . . . 0.0 111.748 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.2 mt -64.99 135.34 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -121.01 22.64 10.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.773 1.229 . . . . 0.0 111.702 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -71.15 157.1 90.95 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.91 121.68 7.82 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.988 2.459 . . . . 0.0 111.33 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.41 161.29 20.39 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.92 142.57 40.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 166.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.22 154.89 50.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.116 0.566 . . . . 0.0 109.786 -169.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -1.305 . . . . 0.0 109.968 -169.801 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.05 145.36 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.01 1.324 . . . . 0.0 108.398 -171.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -140.99 164.37 30.45 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.865 2.066 . . . . 0.0 106.629 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -129.82 128.37 42.18 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -130.99 113.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.71 105.26 12.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 107.709 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.3 2.93 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.871 0.868 . . . . 0.0 112.102 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 4.3 ttp180 -63.28 162.52 11.98 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.645 1.978 . . . . 0.0 110.297 175.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.49 145.47 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.775 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.14 -25.03 31.86 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.255 1.97 . . . . 0.0 112.355 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.65 -31.38 69.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.672 0.789 . . . . 0.0 111.398 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -86.29 -28.69 23.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.512 -0.743 . . . . 0.0 110.362 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -35.5 74.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.425 -0.797 . . . . 0.0 111.257 169.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -69.66 0.63 5.19 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -122.7 -31.19 3.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.61 1.096 . . . . 0.0 111.413 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.76 144.77 16.77 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.827 0.851 . . . . 0.0 109.147 169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -153.17 156.79 39.25 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.758 1.623 . . . . 0.0 108.054 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.89 143.57 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -76.04 48.23 0.48 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.718 1.607 . . . . 0.0 110.827 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.55 42.57 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.008 -1.058 . . . . 0.0 111.982 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.25 -179.55 6.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.982 1.313 . . . . 0.0 109.835 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.75 142.37 43.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 171.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.8 123.77 38.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.3 mt -143.41 100.68 5.2 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.21 150.66 86.05 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.725 1.617 . . . . 0.0 109.163 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -48.09 -46.07 33.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -59.65 -32.29 70.32 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.592 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.37 -45.29 18.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.316 0.646 . . . . 0.0 109.979 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -39.28 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 111.562 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.63 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -99.21 -51.29 3.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.934 0.788 . . . . 0.0 109.582 172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -66.79 -24.91 66.24 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.737 1.215 . . . . 0.0 113.208 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -57.1 -33.08 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.536 1.062 . . . . 0.0 109.772 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -7.53 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.3 m -116.79 -29.06 6.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.783 1.233 . . . . 0.0 110.149 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.96 -34.44 57.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.182 0.593 . . . . 0.0 111.664 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 t -142.35 64.33 16.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.874 2.07 . . . . 0.0 107.501 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.61 -24.55 48.16 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.644 2.229 . . . . 0.0 112.861 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.08 -11.7 59.74 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 59.53 -15.37 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.809 2.444 . . . . 0.0 117.249 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.72 -28.9 51.0 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.556 1.071 . . . . 0.0 113.059 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.99 136.33 55.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.1 m -65.02 101.48 0.52 Allowed 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.827 1.251 . . . . 0.0 109.403 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 113.23 17.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -95.11 101.3 13.04 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.31 141.84 14.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -146.83 164.91 31.31 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.195 0.998 . . . . 0.0 109.422 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.8 p -147.77 -147.1 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.808 1.243 . . . . 0.0 109.19 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.08 -47.05 78.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.868 0.758 . . . . 0.0 111.312 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.17 -35.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.14 -28.14 0.24 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.499 1.045 . . . . 0.0 115.008 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ptt85 -57.05 -46.29 82.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.336 1.568 . . . . 0.0 112.529 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -81.56 -36.72 28.75 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.0 p -69.72 -30.4 68.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.571 -0.706 . . . . 0.0 111.035 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -50.84 63.17 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -59.87 -43.06 94.93 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.604 174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.05 -37.99 84.57 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.013 0.824 . . . . 0.0 111.991 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -61.27 -44.06 97.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.822 1.192 . . . . 0.0 109.603 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.85 -47.72 76.92 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.44 -49.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 0.0 110.261 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 mt -70.47 -30.14 66.87 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.07 0.85 . . . . 0.0 111.3 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.0 m -64.21 -43.09 96.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.122 0.419 . . . . 0.0 109.965 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.6 -33.27 75.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.775 0.716 . . . . 0.0 111.512 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.7 mmm -68.63 -6.61 26.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.474 1.109 . . . . 0.0 112.306 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.51 21.1 60.73 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.001 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -65.67 119.44 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.117 1.458 . . . . 0.0 107.304 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -77.83 -15.4 59.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.15 0.58 . . . . 0.0 111.673 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -136.09 122.97 21.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.09 149.0 20.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.85 162.45 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.73 131.71 53.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.04 19.22 14.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.604 0.762 . . . . 0.0 111.496 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.43 -103.33 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.77 168.65 33.9 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 122.042 0.801 . . . . 0.0 112.811 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.46 -21.62 66.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.269 1.028 . . . . 0.0 113.713 -168.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -65.55 -39.39 91.65 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.147 0.579 . . . . 0.0 111.193 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.05 -34.43 29.47 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.912 0.485 . . . . 0.0 110.795 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.94 131.64 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.12 24.84 9.32 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.658 1.183 . . . . 0.0 111.61 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.5 mtp -68.94 159.39 82.94 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.41 141.59 24.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.215 2.61 . . . . 0.0 111.893 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -115.71 165.11 13.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.703 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.41 144.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -140.76 168.32 20.09 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.615 0.766 . . . . 0.0 109.837 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.604 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -159.6 144.59 15.4 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.586 1.155 . . . . 0.0 108.056 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -148.22 150.24 33.37 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.157 1.383 . . . . 0.0 109.219 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -97.05 121.01 38.46 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -118.41 114.12 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.27 112.14 12.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.64 3.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.735 0.814 . . . . 0.0 111.78 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 5.3 ttp180 -65.14 162.64 16.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.905 2.082 . . . . 0.0 110.191 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.77 143.81 90.56 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.52 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.29 -16.75 27.94 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.852 2.368 . . . . 0.0 112.967 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.67 -37.41 78.66 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.283 -0.885 . . . . 0.0 110.732 173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.89 -29.7 32.27 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.032 0.378 . . . . 0.0 110.986 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -56.51 -39.6 73.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.855 0.752 . . . . 0.0 111.049 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.65 -10.43 52.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.708 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -96.0 -50.13 4.99 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.371 0.987 . . . . 0.0 109.924 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -156.78 146.37 20.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.648 1.179 . . . . 0.0 108.661 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -156.15 162.49 40.22 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.614 1.165 . . . . 0.0 110.534 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.99 139.93 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -60.92 118.39 6.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.009 0.924 . . . . 0.0 109.423 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.82 4.79 89.57 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.191 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 153.55 43.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.647 1.723 . . . . 0.0 110.964 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.65 157.47 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.55 123.66 42.51 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 166.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.94 98.57 6.24 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -60.07 152.85 62.35 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.008 1.805 . . . . 0.0 108.55 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 57' ' ' ALA . 20.8 tp -46.92 -43.56 19.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -167.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.13 -42.15 89.95 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.236 -0.915 . . . . 0.0 111.088 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.51 -32.51 60.54 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.78 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 122.135 2.243 . . . . 0.0 109.591 -171.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -72.39 3.51 4.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.885 1.274 . . . . 0.0 113.751 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.23 -13.41 1.58 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.248 1.419 . . . . 0.0 111.867 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -132.02 -16.89 2.81 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.31 1.444 . . . . 0.0 112.504 -168.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.46 -41.71 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 120.659 1.572 . . . . 0.0 108.945 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.72 -26.38 61.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -73.56 -25.9 60.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.694 0.798 . . . . 0.0 111.525 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.89 -22.27 9.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.177 0.991 . . . . 0.0 112.063 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -144.08 66.51 14.6 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 128.176 2.59 . . . . 0.0 106.55 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.77 -20.24 35.04 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.535 2.156 . . . . 0.0 112.004 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -69.51 102.39 1.8 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.576 0.75 . . . . 0.0 109.744 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -63.45 -16.23 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.42 8.21 45.16 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.318 1.047 . . . . 0.0 110.589 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.03 145.5 55.77 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.672 -1.267 . . . . 0.0 108.951 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.1 m -75.4 79.46 2.46 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 109.982 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -76.56 96.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -73.23 139.56 46.31 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 169.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.56 133.55 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -143.07 164.1 31.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.269 0.627 . . . . 0.0 110.505 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.2 p -148.84 -141.91 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.601 1.161 . . . . 0.0 109.886 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.38 -47.9 71.86 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 110.698 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 -9.18 0.3 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.97 -20.67 2.67 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.539 1.063 . . . . 0.0 113.695 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -49.88 -34.58 20.59 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -124.86 -20.46 4.99 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.514 0.726 . . . . 0.0 112.023 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -66.5 -33.95 76.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.549 1.068 . . . . 0.0 111.161 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.47 -48.62 79.52 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.43 -38.05 83.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.526 -0.396 . . . . 0.0 110.72 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -61.45 -36.72 81.21 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.262 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -56.37 -42.54 78.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.93 0.786 . . . . 0.0 109.69 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.61 -35.06 46.14 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.98 -0.45 . . . . 0.0 109.87 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -64.17 -41.1 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.498 0.719 . . . . 0.0 109.898 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.4 mt -70.67 -32.53 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 120.918 -1.114 . . . . 0.0 110.955 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -62.85 -38.42 90.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.694 0.679 . . . . 0.0 110.417 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.8 -35.25 79.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.234 1.014 . . . . 0.0 110.81 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.3 mmm -67.42 -7.17 23.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 112.382 169.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.2 15.89 68.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.714 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -70.0 125.31 26.37 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.244 1.522 . . . . 0.0 107.081 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -93.52 -10.1 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.746 1.218 . . . . 0.0 112.897 -168.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.13 27.93 3.81 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.396 0.617 . . . . 0.0 111.765 -169.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.66 153.65 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.84 0.856 . . . . 0.0 110.08 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.58 134.35 25.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.24 132.85 33.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.23 20.15 10.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.373 1.069 . . . . 0.0 111.219 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.32 -115.43 7.86 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.6 174.02 43.27 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 117.571 0.686 . . . . 0.0 112.141 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.9 mt -54.44 -27.85 40.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.86 -13.59 62.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -127.04 -16.47 5.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.618 1.167 . . . . 0.0 112.341 -175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.0 mt -61.86 149.52 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.308 1.043 . . . . 0.0 110.287 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.57 64.34 1.61 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.477 1.911 . . . . 0.0 107.769 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 17.4 tpt -143.5 147.21 38.72 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.801 2.04 . . . . 0.0 106.353 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.97 154.31 7.43 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.285 2.656 . . . . 0.0 113.275 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.96 175.14 9.74 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.439 1.096 . . . . 0.0 110.37 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.97 148.93 21.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -151.86 155.31 37.9 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.776 -0.578 . . . . 0.0 110.799 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 C-N-CA 124.966 1.27 . . . . 0.0 110.579 -169.402 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.524 0.202 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.89 148.32 25.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.564 1.146 . . . . 0.0 107.92 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -144.54 163.72 33.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 126.382 1.873 . . . . 0.0 107.334 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -125.26 116.24 21.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 mm -112.97 110.94 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.02 95.55 4.2 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -77.83 -1.46 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.709 0.804 . . . . 0.0 112.209 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.6 ttp180 -65.29 165.91 10.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.967 2.507 . . . . 0.0 110.736 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -59.84 146.85 80.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.986 170.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.58 -18.08 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.89 2.393 . . . . 0.0 113.277 -169.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.74 -38.42 90.45 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.324 -0.86 . . . . 0.0 110.79 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.16 -28.63 42.77 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.062 -0.399 . . . . 0.0 111.406 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 87.8 t80 -55.09 -39.41 69.27 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.537 0.735 . . . . 0.0 111.094 170.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -71.77 -3.41 21.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.516 0.727 . . . . 0.0 112.269 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -105.76 -43.8 4.81 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.261 0.937 . . . . 0.0 110.321 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -159.49 140.2 12.36 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.488 1.115 . . . . 0.0 108.661 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -154.03 158.76 41.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.283 1.033 . . . . 0.0 110.326 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.36 134.51 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -61.26 123.1 16.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.578 0.751 . . . . 0.0 109.185 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.6 84.0 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.123 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 171.89 7.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.208 1.504 . . . . 0.0 111.53 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.08 137.47 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 16.8 t-20 -97.26 129.08 44.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 165.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -141.98 122.17 8.29 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 101.67 -3.455 . . . . 0.0 101.67 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.84 145.37 80.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 N-CA-C 108.321 -1.454 . . . . 0.0 108.321 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.2 -38.7 26.95 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -168.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.52 -0.738 . . . . 0.0 111.237 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -80.23 -32.34 38.47 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-O 117.754 -1.117 . . . . 0.0 111.415 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.76 -42.47 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.136 1.335 . . . . 0.0 109.895 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -64.83 -2.36 2.52 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -124.95 -50.14 1.71 Allowed 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.022 -1.049 . . . . 0.0 109.214 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -65.93 -25.62 67.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.645 1.178 . . . . 0.0 112.905 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.64 -31.9 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.559 1.072 . . . . 0.0 109.903 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.06 84.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.363 0.983 . . . . 0.0 111.636 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -37.53 46.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.264 0.626 . . . . 0.0 111.304 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.5 -35.06 40.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.2 0.6 . . . . 0.0 112.299 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.61 69.94 15.3 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.312 1.845 . . . . 0.0 108.549 -169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.36 -22.49 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.347 2.031 . . . . 0.0 112.775 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.88 101.29 3.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.81 0.732 . . . . 0.0 109.969 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -61.99 -15.75 46.27 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 5.84 48.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 110.79 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.55 146.22 54.94 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.676 -1.265 . . . . 0.0 108.947 169.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 m -74.96 80.81 2.17 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 110.233 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.66 93.72 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -70.56 140.39 51.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.84 133.87 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.09 164.89 30.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.297 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 31.1 p -162.64 -162.48 0.8 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.858 1.663 . . . . 0.0 108.789 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.3 118.29 12.92 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.68 24.17 1.14 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.266 1.827 . . . . 0.0 114.991 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 6.68 58.59 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.091 0.853 . . . . 0.0 115.088 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.086 1.443 . . . . 0.0 114.372 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -126.65 -23.46 3.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.304 1.442 . . . . 0.0 110.738 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -30.34 68.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.586 1.085 . . . . 0.0 111.284 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.9 -47.43 91.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.61 -39.18 93.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.392 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.07 94.95 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.224 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -56.26 -45.32 80.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 109.359 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -74.63 -34.3 62.75 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.206 -0.309 . . . . 0.0 110.24 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.15 -45.45 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.001 0.92 . . . . 0.0 110.086 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.9 mt -71.05 -30.84 67.11 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.272 -0.893 . . . . 0.0 110.622 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.3 m -64.09 -38.63 91.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.313 0.506 . . . . 0.0 110.636 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.287 1.035 . . . . 0.0 110.424 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -70.08 -5.08 24.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.707 0.803 . . . . 0.0 112.613 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.42 66.83 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.839 -0.978 . . . . 0.0 113.241 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -68.66 131.93 46.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.217 1.508 . . . . 0.0 107.417 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.0 p -97.9 -6.54 32.12 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.77 29.43 2.34 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.752 0.705 . . . . 0.0 112.012 -173.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 m -55.68 150.48 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.248 0.619 . . . . 0.0 109.435 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -145.8 126.11 13.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.62 134.99 37.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.35 17.3 10.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.317 1.047 . . . . 0.0 111.495 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.89 -115.16 7.57 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 123.874 0.75 . . . . 0.0 111.334 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.21 170.68 35.6 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.431 0.538 . . . . 0.0 112.128 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.06 -21.69 9.01 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.882 1.673 . . . . 0.0 115.228 -168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.88 -17.35 61.05 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.988 0.813 . . . . 0.0 112.718 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.41 -9.71 4.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.025 0.83 . . . . 0.0 112.565 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.5 -37.14 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.764 -0.585 . . . . 0.0 112.141 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.63 60.14 3.5 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.235 1.414 . . . . 0.0 112.595 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.6 mmm -129.58 163.66 45.19 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.053 1.741 . . . . 0.0 108.093 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -57.92 156.02 30.49 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.338 2.025 . . . . 0.0 111.097 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -134.83 171.52 14.28 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.468 1.107 . . . . 0.0 110.724 -169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.3 t -138.1 144.42 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 167.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -140.85 157.83 44.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.06 0.544 . . . . 0.0 109.534 -170.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.16 148.06 23.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.411 1.084 . . . . 0.0 109.434 -171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.09 162.02 36.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.876 2.07 . . . . 0.0 107.159 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -128.16 128.59 45.09 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -130.78 109.99 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -73.05 98.0 2.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.804 1.242 . . . . 0.0 107.659 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 m -78.28 -1.36 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.671 0.788 . . . . 0.0 111.989 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.7 ttp180 -64.18 163.85 11.94 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.547 2.339 . . . . 0.0 110.744 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.86 146.46 37.2 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.785 170.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.45 -20.68 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 114.006 -168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.23 -49.21 75.05 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.086 0.857 . . . . 0.0 110.023 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.14 -26.84 67.62 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.571 -0.706 . . . . 0.0 111.569 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.07 -44.1 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.527 0.731 . . . . 0.0 111.524 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -63.32 -35.95 82.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -75.14 -36.55 61.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.418 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.41 146.51 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.607 1.563 . . . . 0.0 109.204 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -151.36 155.92 39.66 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.249 1.42 . . . . 0.0 110.357 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.51 133.25 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -51.92 121.09 6.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.451 1.101 . . . . 0.0 110.323 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.34 77.37 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.581 -1.121 . . . . 0.0 114.888 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.16 39.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.683 1.741 . . . . 0.0 110.741 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.4 158.09 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -123.93 131.42 53.57 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 165.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -147.26 127.51 6.8 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.4 145.09 82.18 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 121.127 1.438 . . . . 0.0 109.244 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -51.03 -36.53 40.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.32 -43.17 78.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.745 0.818 . . . . 0.0 111.085 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.04 -38.65 56.92 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.964 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.7 t -49.46 -40.45 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.529 1.059 . . . . 0.0 110.772 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -63.0 -9.44 10.08 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.55 -45.51 2.06 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.05 0.841 . . . . 0.0 109.533 168.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -68.39 -20.37 64.68 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.594 1.157 . . . . 0.0 112.767 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.2 tp -58.44 -37.38 63.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 119.986 1.266 . . . . 0.0 109.02 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.75 -29.55 68.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.095 0.861 . . . . 0.0 112.048 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -71.93 -21.15 61.66 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.289 1.036 . . . . 0.0 111.654 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.25 -21.06 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.528 1.131 . . . . 0.0 112.715 -172.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.02 52.05 2.77 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.871 2.069 . . . . 0.0 108.427 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.41 -29.69 53.62 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.349 1.161 . . . . 0.0 111.555 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.48 104.16 9.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -57.87 -16.9 13.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.531 1.132 . . . . 0.0 113.845 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -71.65 -23.25 61.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.04 0.836 . . . . 0.0 112.678 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 130.91 44.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.169 0.895 . . . . 0.0 108.687 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 m -64.09 148.85 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.11 131.26 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -112.14 90.78 3.43 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -74.78 142.59 14.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -144.5 165.43 27.99 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.86 0.864 . . . . 0.0 110.38 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.5 p -150.47 -155.75 0.66 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.952 1.701 . . . . 0.0 107.964 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.45 -51.24 61.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.552 1.069 . . . . 0.0 111.569 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.49 -3.89 1.88 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.61 -17.74 9.44 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.112 0.869 . . . . 0.0 114.052 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.13 -60.21 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.925 1.362 . . . . 0.0 111.089 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -70.54 -33.14 70.81 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 p -71.78 -32.9 68.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.724 0.693 . . . . 0.0 111.501 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.19 84.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -61.83 -40.89 96.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.581 174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.59 90.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.174 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -57.34 -46.52 83.2 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -72.89 -35.05 67.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.57 -51.22 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.11 0.964 . . . . 0.0 109.881 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.27 -34.14 75.64 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.89 0.768 . . . . 0.0 110.559 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.5 m -64.71 -39.86 94.38 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.07 -0.394 . . . . 0.0 110.542 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.63 -35.35 79.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.596 1.159 . . . . 0.0 110.765 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mtp -69.23 -1.09 7.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.571 1.148 . . . . 0.0 112.262 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.36 17.91 72.65 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.017 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -66.27 119.45 11.54 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 p -77.45 -14.42 59.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 112.389 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -132.96 111.72 11.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.84 145.33 25.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -144.34 151.15 38.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -103.75 113.33 26.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.53 -35.95 68.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.055 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.92 -137.35 9.48 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.83 154.17 20.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.6 tp -52.71 -34.82 54.16 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.419 1.487 . . . . 0.0 112.514 -169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -62.98 -15.83 57.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -125.94 -14.14 6.17 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 112.485 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.31 124.5 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.342 0.657 . . . . 0.0 109.482 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.51 58.29 4.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.565 1.546 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.4 mmm -129.03 156.02 78.81 Favored Pre-proline 0 C--O 1.239 0.509 0 C-N-CA 125.174 1.39 . . . . 0.0 108.465 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 155.79 62.42 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.818 2.345 . . . . 0.0 110.68 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -137.7 156.34 48.12 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.772 0.829 . . . . 0.0 109.594 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -138.65 160.58 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.059 1.744 . . . . 0.0 106.495 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -151.84 171.18 18.14 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.215 1.406 . . . . 0.0 109.447 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.475 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -151.88 144.59 24.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.866 1.266 . . . . 0.0 108.46 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -140.88 164.38 30.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.717 2.007 . . . . 0.0 106.913 168.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -128.33 130.65 48.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mm -132.67 107.56 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -171.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.97 126.67 30.2 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.22 18.02 6.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.472 1.109 . . . . 0.0 111.153 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -84.01 165.61 18.46 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.418 1.487 . . . . 0.0 109.544 -172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 m -60.45 136.94 92.2 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.13 -22.75 29.95 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.247 1.964 . . . . 0.0 112.693 -169.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.34 -34.16 77.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.406 -0.809 . . . . 0.0 110.93 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.9 -32.56 25.07 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.661 -0.649 . . . . 0.0 110.869 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -56.74 -43.29 80.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.884 0.766 . . . . 0.0 110.529 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.05 -29.07 70.53 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.679 -0.638 . . . . 0.0 112.111 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -77.15 -38.06 52.68 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.813 0.733 . . . . 0.0 111.243 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -156.91 136.33 12.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.814 0.734 . . . . 0.0 109.344 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -149.57 164.73 34.31 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.884 0.873 . . . . 0.0 109.923 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.02 150.02 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -76.03 55.2 0.9 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.377 1.471 . . . . 0.0 110.65 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.72 -146.14 9.81 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 127.035 2.255 . . . . 0.0 107.711 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.88 -175.37 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.788 1.635 . . . . 0.0 113.766 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mm -130.8 153.82 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.985 2.114 . . . . 0.0 105.687 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.84 122.28 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -140.63 92.85 8.84 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -57.9 152.49 50.18 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.453 2.102 . . . . 0.0 109.247 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -51.35 -38.54 53.7 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.83 -34.25 77.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.403 -0.811 . . . . 0.0 112.841 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -78.88 -42.41 27.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.847 0.859 . . . . 0.0 110.616 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -36.47 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.768 0.713 . . . . 0.0 111.082 -168.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -1.03 1.55 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.21 -48.46 1.0 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.365 1.066 . . . . 0.0 108.924 168.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -67.28 -23.97 65.73 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.599 1.16 . . . . 0.0 112.713 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.24 -34.76 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 120.284 1.402 . . . . 0.0 109.829 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -17.93 60.34 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.7 m -103.57 -33.2 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.021 0.929 . . . . 0.0 110.173 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.88 -33.41 52.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.254 0.622 . . . . 0.0 111.855 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -141.91 71.92 23.82 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.833 2.053 . . . . 0.0 106.833 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -66.81 -28.29 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 121.894 1.729 . . . . 0.0 111.794 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -84.66 102.62 13.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.479 0.712 . . . . 0.0 109.464 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -58.74 -14.13 7.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.567 1.147 . . . . 0.0 114.031 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -73.93 -24.36 59.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.302 0.955 . . . . 0.0 113.057 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.6 132.63 47.9 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.193 0.906 . . . . 0.0 109.87 -176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -67.03 102.8 1.04 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.369 1.068 . . . . 0.0 109.374 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 t -80.23 119.83 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -102.06 102.39 12.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.84 141.95 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.64 168.51 20.49 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.299 1.04 . . . . 0.0 110.05 172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.94 -159.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 107.255 -170.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -68.73 -47.69 65.66 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.685 0.794 . . . . 0.0 109.677 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.83 161.5 37.66 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.266 1.826 . . . . 0.0 108.157 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.59 -18.41 63.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.734 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.8 -47.91 78.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.081 1.941 . . . . 0.0 112.188 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -78.05 -36.28 48.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.45 0.568 . . . . 0.0 109.914 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 p -70.77 -27.88 64.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.935 0.789 . . . . 0.0 110.903 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.0 -47.61 58.91 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -57.34 -43.02 83.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.101 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.46 83.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.101 0.864 . . . . 0.0 112.046 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.81 -45.91 90.88 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.419 1.009 . . . . 0.0 109.365 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.02 -46.83 76.5 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.3 mt -59.31 -48.96 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.218 1.407 . . . . 0.0 110.016 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.0 mt -68.65 -32.35 72.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.163 0.892 . . . . 0.0 111.052 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -64.08 -40.47 96.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.287 0.494 . . . . 0.0 110.237 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.59 -31.36 71.36 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.443 -0.785 . . . . 0.0 111.443 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mtp -70.95 0.27 7.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.887 0.875 . . . . 0.0 112.28 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.35 13.82 72.76 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.557 -1.135 . . . . 0.0 113.205 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -65.29 117.81 8.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.369 1.585 . . . . 0.0 107.174 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.9 p -79.12 -13.11 59.94 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.301 0.641 . . . . 0.0 111.392 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -133.57 117.92 17.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -141.12 145.11 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -141.45 153.26 44.88 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -105.11 112.53 25.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.37 60.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.178 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.44 -141.72 13.04 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.02 154.61 18.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.5 tp -63.73 -21.55 66.46 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.72 -22.8 66.06 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.263 0.625 . . . . 0.0 112.39 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -110.35 -26.45 9.56 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.263 1.025 . . . . 0.0 111.473 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.6 139.67 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.84 29.08 5.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.026 1.33 . . . . 0.0 111.223 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 86.8 mmm -64.84 161.71 43.75 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 109.209 168.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.76 142.03 15.06 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.11 2.54 . . . . 0.0 110.609 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -130.22 166.15 20.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.511 0.672 . . . . 0.0 111.758 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.04 156.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 168.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -140.96 159.36 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.689 1.196 . . . . 0.0 108.977 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 175.297 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.04 145.55 16.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.676 1.19 . . . . 0.0 108.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -147.83 139.54 23.91 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.051 1.34 . . . . 0.0 108.093 168.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.17 121.06 28.22 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 167.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.5 mm -122.71 103.98 13.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -72.02 112.03 7.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.475 1.11 . . . . 0.0 108.503 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.43 2.94 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.174 0.989 . . . . 0.0 111.807 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.3 ttp180 -63.17 163.71 9.77 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.312 1.845 . . . . 0.0 109.834 169.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 m -60.32 144.3 88.06 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.1 -18.55 30.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.834 2.356 . . . . 0.0 112.563 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -62.23 -29.11 70.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.285 -0.885 . . . . 0.0 111.296 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 -28.15 22.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.77 0.714 . . . . 0.0 111.033 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 64.1 t80 -56.41 -37.49 70.25 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.392 0.997 . . . . 0.0 111.404 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -67.72 -16.63 64.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.433 0.693 . . . . 0.0 112.596 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -94.21 -45.78 7.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.336 0.971 . . . . 0.0 110.346 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -157.37 145.81 19.42 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.163 0.985 . . . . 0.0 109.108 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -149.53 162.98 39.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.366 1.067 . . . . 0.0 109.767 169.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.7 t -70.01 143.69 14.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -54.04 118.87 4.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 110.276 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.11 4.6 86.48 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.577 -1.124 . . . . 0.0 114.479 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.58 53.48 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.696 1.748 . . . . 0.0 111.19 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.92 156.89 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 169.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.434 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 19.8 t-20 -116.35 125.6 52.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.73 95.43 7.84 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.54 153.57 70.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.594 1.53 . . . . 0.0 108.625 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 57' ' ' ALA . 27.3 tp -51.09 -39.04 55.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -168.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -60.66 -39.27 87.76 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.63 -45.36 30.33 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.727 0.811 . . . . 0.0 111.11 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -35.43 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.974 0.806 . . . . 0.0 112.071 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.96 -12.68 8.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.526 1.13 . . . . 0.0 113.783 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -122.9 -47.16 2.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.012 0.925 . . . . 0.0 109.651 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -68.0 -23.75 65.05 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.514 1.125 . . . . 0.0 112.823 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.16 -34.74 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.38 1.446 . . . . 0.0 109.504 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.7 78.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.973 0.806 . . . . 0.0 111.827 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -74.37 -43.12 57.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.965 0.906 . . . . 0.0 110.373 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.42 -33.87 31.92 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.548 0.739 . . . . 0.0 112.252 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.8 t -145.3 72.64 14.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.594 1.957 . . . . 0.0 107.121 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.41 -30.73 72.64 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.703 1.602 . . . . 0.0 112.029 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.54 108.62 2.08 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.925 0.89 . . . . 0.0 110.794 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.38 -25.94 68.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.83 0.852 . . . . 0.0 112.207 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -87.85 3.16 49.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.357 1.063 . . . . 0.0 111.651 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.92 143.56 57.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 120.498 -1.376 . . . . 0.0 109.917 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -76.45 79.12 3.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.691 0.758 . . . . 0.0 110.007 172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.62 100.47 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -81.95 97.8 8.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 135.91 26.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -144.76 160.93 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.243 0.617 . . . . 0.0 110.07 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 25.5 p -143.74 -154.21 0.51 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.882 1.273 . . . . 0.0 109.36 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.58 -42.21 96.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.333 -0.854 . . . . 0.0 111.856 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.78 -39.05 0.24 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.12 -25.85 0.27 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.274 0.943 . . . . 0.0 115.277 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -64.03 -46.56 83.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.856 1.828 . . . . 0.0 112.565 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.25 -35.98 66.32 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.077 0.399 . . . . 0.0 110.08 -176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.2 p -71.3 -28.12 63.9 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.616 0.644 . . . . 0.0 111.324 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.92 72.4 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -60.43 -45.01 95.17 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.411 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 26' ' ' LEU . . . -57.09 -41.02 78.12 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 118.654 0.661 . . . . 0.0 111.853 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -58.37 -48.13 81.58 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.776 0.716 . . . . 0.0 109.212 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -72.74 -37.19 67.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.3 mt -57.54 -51.66 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.252 1.021 . . . . 0.0 109.539 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.4 -35.59 77.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.788 0.722 . . . . 0.0 111.2 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.1 m -64.46 -41.87 96.26 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.09 -0.382 . . . . 0.0 110.351 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.16 -37.66 84.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.071 0.948 . . . . 0.0 110.517 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 65.5 mtp -61.37 -31.72 71.62 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.976 0.511 . . . . 0.0 111.372 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.2 11.08 4.37 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.583 170.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -65.61 140.51 58.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.659 1.729 . . . . 0.0 107.824 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 p -111.44 -4.9 14.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.334 1.054 . . . . 0.0 112.883 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -138.92 27.23 2.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.752 0.705 . . . . 0.0 111.869 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.08 145.48 9.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -135.36 139.11 43.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.72 130.44 41.24 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.7 20.16 14.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.004 0.921 . . . . 0.0 111.172 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.28 -114.36 6.46 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.42 175.17 41.23 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 75' ' ' LEU . 3.2 mm? -52.25 -30.7 28.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.788 1.235 . . . . 0.0 113.599 -167.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.8 -14.61 62.03 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.409 1.084 . . . . 0.0 112.837 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.26 -16.7 5.39 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.567 1.147 . . . . 0.0 112.121 -174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.32 142.53 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.23 57.12 1.08 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.073 1.749 . . . . 0.0 108.026 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -144.21 142.34 19.71 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.18 154.44 28.49 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.643 2.229 . . . . 0.0 112.994 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -113.33 167.11 10.84 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.149 0.98 . . . . 0.0 109.933 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.22 140.35 48.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 167.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -131.71 151.91 51.29 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 108.959 -169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 173.742 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -152.03 143.87 23.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.823 1.249 . . . . 0.0 108.535 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -140.01 165.01 28.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.687 1.995 . . . . 0.0 106.755 167.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -129.78 119.36 23.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -124.06 100.61 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.26 129.67 42.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 108.739 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m -108.53 4.11 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.642 0.777 . . . . 0.0 111.95 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 8.0 ttp180 -60.81 164.42 4.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.251 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 m -59.38 144.08 84.48 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.41 -18.98 22.55 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.575 2.183 . . . . 0.0 112.589 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.95 -35.6 77.17 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.41 -0.806 . . . . 0.0 110.804 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -80.9 -30.44 35.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.431 . . . . 0.0 110.919 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 71.1 t80 -58.82 -36.5 74.61 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.712 0.687 . . . . 0.0 110.802 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.51 0.42 10.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.942 0.897 . . . . 0.0 112.757 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -108.16 -46.52 3.72 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.607 1.094 . . . . 0.0 109.989 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -156.15 147.21 22.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 108.852 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -152.29 161.28 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.535 1.134 . . . . 0.0 110.058 170.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.53 136.19 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -53.73 120.72 6.61 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.57 -3.69 84.27 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.475 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.05 149.56 46.43 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.632 1.716 . . . . 0.0 110.687 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 mm -85.68 163.64 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 9.3 t-20 -129.9 131.28 45.98 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.8 mt -142.41 115.75 6.39 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.57 150.2 88.48 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.627 1.551 . . . . 0.0 109.465 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.4 -39.38 57.11 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -167.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.33 -40.53 82.35 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.833 -0.542 . . . . 0.0 110.942 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.18 -35.51 21.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.797 0.839 . . . . 0.0 111.916 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -35.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.537 1.062 . . . . 0.0 110.716 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -62.04 -11.04 11.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.865 0.866 . . . . 0.0 113.103 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -112.83 -50.16 2.9 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.301 -0.874 . . . . 0.0 108.993 168.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -68.39 -21.13 64.71 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tp -60.17 -33.19 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 119.796 1.18 . . . . 0.0 109.493 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.31 71.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.918 0.781 . . . . 0.0 112.159 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.77 -34.99 19.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.916 176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.08 -32.77 33.81 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.478 0.711 . . . . 0.0 112.004 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 t -141.8 70.65 24.72 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.954 2.101 . . . . 0.0 106.975 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.91 -29.96 40.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.004 1.802 . . . . 0.0 111.747 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.9 98.1 7.72 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.06 -11.25 5.49 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -73.34 -24.07 60.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.276 0.944 . . . . 0.0 112.849 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.16 133.38 49.68 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.183 0.901 . . . . 0.0 109.523 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -66.46 102.02 0.83 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.043 0.937 . . . . 0.0 109.2 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.12 104.91 7.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -82.91 138.75 33.74 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.3 142.9 40.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.07 167.93 22.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.778 1.231 . . . . 0.0 108.049 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.8 -151.25 0.38 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 108.116 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -61.47 -49.09 78.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.576 1.08 . . . . 0.0 111.382 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.43 -9.64 0.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.26 -22.71 3.94 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.487 1.04 . . . . 0.0 113.559 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 tpt85 -54.44 -33.06 58.78 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -120.34 -18.9 7.81 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.467 1.031 . . . . 0.0 112.665 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 p -68.54 -32.21 71.99 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.65 1.114 . . . . 0.0 110.574 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.86 -48.98 74.28 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.6 -37.89 83.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.126 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.98 73.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.095 0.861 . . . . 0.0 112.005 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.27 -43.94 95.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.109 0.868 . . . . 0.0 110.057 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -67.54 -46.1 73.77 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.4 mt -56.41 -50.45 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.919 1.288 . . . . 0.0 110.129 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.7 mt -70.93 -31.46 68.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.586 0.63 . . . . 0.0 111.14 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.1 m -64.47 -40.49 95.8 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.301 0.501 . . . . 0.0 110.331 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.92 -32.34 72.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.483 -0.761 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -68.52 -6.65 26.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.468 0.707 . . . . 0.0 112.329 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.98 17.35 59.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.672 -1.071 . . . . 0.0 112.943 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -65.75 118.14 9.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.335 1.567 . . . . 0.0 107.091 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.2 p -78.38 -13.73 59.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.266 0.626 . . . . 0.0 111.2 -170.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -134.2 121.98 22.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -142.87 148.94 19.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.3 150.6 39.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.537 0.608 . . . . 0.0 109.716 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -104.24 128.45 51.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.59 13.72 23.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.578 0.751 . . . . 0.0 111.529 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.88 -116.24 4.98 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.75 166.81 30.92 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 117.475 0.638 . . . . 0.0 111.8 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.03 -30.37 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.261 1.424 . . . . 0.0 113.482 -168.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.04 -37.96 87.16 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.297 0.639 . . . . 0.0 111.518 176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.34 -34.12 28.62 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.988 0.515 . . . . 0.0 110.81 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.39 131.07 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 23.51 10.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.772 1.229 . . . . 0.0 111.647 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mtp -69.41 162.91 63.12 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.608 1.163 . . . . 0.0 108.56 168.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.88 147.47 73.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.059 1.839 . . . . 0.0 110.838 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -119.23 164.28 15.85 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.062 0.945 . . . . 0.0 109.442 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.7 t -126.18 141.43 45.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 167.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.7 150.19 51.52 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.053 0.941 . . . . 0.0 108.923 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -171.269 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.525 0.202 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -153.6 148.22 26.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -143.83 156.25 44.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.073 1.749 . . . . 0.0 106.348 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -116.55 125.69 52.23 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 172.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -122.31 114.78 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.04 117.63 12.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 29' ' ' VAL . 17.1 m -117.89 6.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.6 1.16 . . . . 0.0 112.48 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -74.03 -178.33 3.27 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.08 143.28 72.68 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.958 -0.464 . . . . 0.0 109.847 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.39 -22.46 33.73 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.608 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.91 -38.11 81.38 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.687 0.795 . . . . 0.0 111.225 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -71.82 -34.48 69.37 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.237 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 64.7 t80 -61.26 -32.01 71.82 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.599 0.636 . . . . 0.0 110.37 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -67.22 -21.99 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.417 0.553 . . . . 0.0 111.577 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -84.58 -53.56 5.32 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.917 0.78 . . . . 0.0 109.407 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.44 148.29 16.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.51 1.124 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -150.7 162.09 41.37 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.31 1.044 . . . . 0.0 110.274 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.89 138.27 23.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -57.21 128.0 34.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.51 0.724 . . . . 0.0 109.81 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.09 4.56 83.69 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.853 -0.971 . . . . 0.0 114.28 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.77 172.55 8.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.199 1.5 . . . . 0.0 111.887 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.0 162.71 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.735 2.014 . . . . 0.0 105.643 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 6.4 t-20 -127.03 132.57 50.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 166.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 mt -148.62 119.25 4.21 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.77 148.95 91.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.264 1.487 . . . . 0.0 109.51 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -51.73 -37.09 49.52 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -58.91 -34.36 71.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.633 0.773 . . . . 0.0 112.629 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -84.4 -37.46 21.46 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.555 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 HG12 ' A' ' 7' ' ' VAL . 54.4 t -49.07 -41.41 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.322 1.049 . . . . 0.0 110.829 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.96 -4.86 3.71 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.24 -49.0 1.44 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.121 0.968 . . . . 0.0 108.786 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -68.12 -24.14 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.373 1.069 . . . . 0.0 113.043 -171.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.78 -31.87 50.54 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 119.782 1.174 . . . . 0.0 109.265 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.35 80.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.649 1.113 . . . . 0.0 111.273 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -70.31 -44.79 67.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.952 0.901 . . . . 0.0 110.221 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.86 30.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.443 0.697 . . . . 0.0 112.762 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.9 66.87 12.01 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.599 1.96 . . . . 0.0 108.587 -169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.54 -22.15 51.79 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.949 1.099 . . . . 0.0 111.939 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.46 100.43 2.21 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.708 0.803 . . . . 0.0 109.849 171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -59.93 -17.99 41.84 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.932 0.893 . . . . 0.0 113.322 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.33 7.11 47.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.334 0.97 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 144.65 57.08 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.658 -1.276 . . . . 0.0 109.147 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -76.72 81.46 3.34 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.22 110.97 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -97.03 94.89 7.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -75.03 138.78 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -145.8 154.5 42.08 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.547 0.739 . . . . 0.0 110.174 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.0 p -134.53 -144.38 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.632 1.173 . . . . 0.0 107.926 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.72 -47.27 66.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.664 1.12 . . . . 0.0 110.805 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.46 -26.21 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.35 -24.23 0.31 Allowed Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.871 1.214 . . . . 0.0 115.464 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -61.82 -50.07 73.75 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.551 1.675 . . . . 0.0 113.012 -169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.46 -34.37 54.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.545 0.611 . . . . 0.0 110.238 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.6 p -70.07 -29.78 66.86 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.677 0.672 . . . . 0.0 110.964 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.06 -48.85 76.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -60.52 -39.7 88.77 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.433 173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.47 93.06 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.341 0.656 . . . . 0.0 111.983 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.94 -42.43 98.18 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 109.389 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.49 -43.33 77.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 mt -55.37 -50.33 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.229 1.012 . . . . 0.0 110.051 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.43 -31.51 65.55 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.657 -0.652 . . . . 0.0 111.259 -176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.9 m -62.59 -41.37 98.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.364 0.529 . . . . 0.0 110.169 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -68.49 -31.75 71.24 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.493 0.717 . . . . 0.0 111.422 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -6.93 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.484 0.713 . . . . 0.0 112.194 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.38 64.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.567 -1.129 . . . . 0.0 112.752 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -67.3 132.21 47.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.415 1.607 . . . . 0.0 106.915 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 p -100.74 -6.36 25.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.348 1.059 . . . . 0.0 113.108 -167.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.5 24.75 3.17 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.829 0.741 . . . . 0.0 112.321 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.68 144.24 14.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -136.6 151.17 49.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.41 125.44 50.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.2 14.44 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.344 0.658 . . . . 0.0 111.481 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 -112.11 3.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.73 169.74 40.22 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 117.699 0.75 . . . . 0.0 111.664 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.21 -34.64 61.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.644 0.778 . . . . 0.0 112.502 -169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.4 -12.4 61.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -120.87 -22.34 6.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.674 1.189 . . . . 0.0 111.985 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.24 136.57 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 108.964 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.98 22.0 14.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.658 1.183 . . . . 0.0 112.218 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.6 mmm -80.11 158.57 72.1 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 124.458 1.103 . . . . 0.0 108.764 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.15 154.36 14.12 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.758 2.972 . . . . 0.0 112.408 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -136.42 163.03 31.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.35 1.06 . . . . 0.0 109.212 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.7 t -134.75 125.12 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -85.98 158.01 19.98 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.358 0.663 . . . . 0.0 109.509 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 170.826 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -150.71 147.21 27.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -143.49 164.98 28.83 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.09 2.156 . . . . 0.0 106.61 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' C ' HD12 ' A' ' 5' ' ' ILE . 36.1 m95 -133.7 123.46 24.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.3 mp -121.91 116.72 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -70.88 129.15 38.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.023 1.329 . . . . 0.0 107.961 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.04 5.46 7.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.406 1.082 . . . . 0.0 111.701 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -71.53 171.21 11.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.247 0.93 . . . . 0.0 109.878 171.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.23 139.57 79.56 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.34 -25.31 49.37 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.149 1.899 . . . . 0.0 112.99 -169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -60.79 -25.08 66.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.608 1.094 . . . . 0.0 112.034 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -84.32 -33.6 23.88 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.52 -0.738 . . . . 0.0 110.763 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -38.61 81.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.746 0.703 . . . . 0.0 110.641 170.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -61.74 -19.92 62.97 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.174 0.59 . . . . 0.0 112.044 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -96.76 -45.02 6.83 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 119.149 0.886 . . . . 0.0 110.591 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -160.47 139.83 10.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.778 0.717 . . . . 0.0 110.823 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -149.33 164.39 35.03 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.358 1.863 . . . . 0.0 109.177 172.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.56 142.39 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.516 0.726 . . . . 0.0 109.105 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 -28.87 68.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.796 0.838 . . . . 0.0 113.172 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.3 40.31 2.59 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.942 1.258 . . . . 0.0 111.759 -173.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.73 13.73 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.461 1.105 . . . . 0.0 111.221 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.45 166.78 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.336 1.854 . . . . 0.0 106.804 171.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -121.47 127.03 50.66 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 164.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.3 mt -141.98 107.44 5.81 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 102.701 -3.074 . . . . 0.0 102.701 171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.18 154.49 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.629 1.552 . . . . 0.0 109.362 -172.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.7 tp -52.72 -39.03 61.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -59.69 -30.64 68.92 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -91.36 -43.78 9.56 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.568 0.747 . . . . 0.0 110.656 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -35.07 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 118.652 0.66 . . . . 0.0 111.706 -168.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -59.05 -17.07 22.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.54 1.136 . . . . 0.0 113.422 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -115.77 -47.34 2.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.754 0.822 . . . . 0.0 109.206 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.73 -22.24 64.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.216 1.007 . . . . 0.0 113.134 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tp -61.04 -34.65 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.872 1.214 . . . . 0.0 109.193 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.43 68.76 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.837 0.744 . . . . 0.0 112.065 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 m -73.8 -13.46 60.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.55 1.14 . . . . 0.0 111.324 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.99 -24.59 3.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.238 1.015 . . . . 0.0 113.54 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.59 40.82 0.35 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.65 1.18 . . . . 0.0 112.206 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.93 -7.63 19.15 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 CA-C-N 121.311 1.504 . . . . 0.0 113.507 -173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.74 -27.41 64.91 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.234 1.413 . . . . 0.0 112.866 169.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 62.52 -11.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.203 2.201 . . . . 0.0 116.656 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.2 3.25 23.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.974 1.716 . . . . 0.0 111.134 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -65.14 146.52 54.87 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.063 -1.023 . . . . 0.0 109.057 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -75.39 82.46 2.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 5' ' ' ILE . 25.3 t -77.51 104.28 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 173.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -80.33 141.09 35.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.24 136.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -144.56 166.8 24.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.688 0.795 . . . . 0.0 109.546 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 21.9 p -147.13 -141.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.955 0.902 . . . . 0.0 108.607 174.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -67.0 -39.44 87.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.373 0.988 . . . . 0.0 111.001 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.76 -41.15 0.28 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -170.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.55 -27.16 0.6 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.693 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -54.68 -59.96 4.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.169 1.484 . . . . 0.0 111.82 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . 0.269 18.4 pt20 -77.43 -16.74 58.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.783 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -63.88 -38.97 93.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.576 1.08 . . . . 0.0 109.92 167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.72 -49.81 66.02 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -58.0 -42.41 85.14 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.502 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.13 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.179 0.9 . . . . 0.0 111.326 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -60.14 -44.29 95.06 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.237 0.926 . . . . 0.0 109.957 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.17 -47.51 76.74 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.24 -50.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 125.466 1.507 . . . . 0.0 110.058 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.5 -33.7 73.22 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.485 0.584 . . . . 0.0 110.717 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 m -64.98 -39.75 93.93 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.465 0.575 . . . . 0.0 110.615 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.15 -36.02 82.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.582 0.753 . . . . 0.0 110.443 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 57.6 mtp -70.0 -1.04 8.62 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.742 1.217 . . . . 0.0 112.701 171.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.75 17.78 67.23 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.026 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -71.53 121.43 18.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -88.13 -9.95 51.58 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -166.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.65 23.19 3.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.891 0.769 . . . . 0.0 112.661 -170.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 t -60.86 145.09 12.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.83 148.43 42.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' A' ' 54' ' ' SER . 19.7 t-20 -88.29 135.95 33.21 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.11 20.11 6.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.545 0.738 . . . . 0.0 112.119 -175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.33 -117.47 7.27 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.6 161.78 29.65 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 118.011 0.906 . . . . 0.0 112.412 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -45.72 -47.81 15.28 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 127.047 2.139 . . . . 0.0 112.273 -169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.67 -19.11 64.63 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.43 -19.82 14.28 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.752 0.821 . . . . 0.0 112.315 -172.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.27 124.45 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.13 54.5 2.54 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.429 1.492 . . . . 0.0 110.881 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -136.05 154.49 77.56 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 125.235 1.414 . . . . 0.0 108.543 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.1 157.96 59.65 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.809 2.339 . . . . 0.0 110.925 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -133.39 169.13 17.38 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.81 0.844 . . . . 0.0 110.704 -167.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.22 149.73 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 126.423 1.889 . . . . 0.0 108.485 -172.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 171.97 13.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.751 0.42 . . . . 0.0 110.207 168.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 C-N-CA 125.023 1.297 . . . . 0.0 112.106 178.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.22 148.27 24.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.42 163.27 34.29 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.386 1.875 . . . . 0.0 107.098 168.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -123.9 116.38 22.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -118.18 104.52 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -66.79 112.13 4.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 108.165 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.32 1.85 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.938 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 6.2 ttp180 -64.05 164.95 9.74 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.974 2.109 . . . . 0.0 110.761 174.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -57.86 142.96 78.11 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.057 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.68 -21.88 28.61 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.285 1.99 . . . . 0.0 112.125 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -68.49 -10.96 58.93 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.516 -0.74 . . . . 0.0 112.98 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -98.78 -25.26 14.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.5 1.045 . . . . 0.0 111.927 173.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 81.0 t80 -53.42 -42.8 67.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.12 0.873 . . . . 0.0 111.656 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -64.69 -18.07 64.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -96.81 -36.18 10.71 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.186 0.994 . . . . 0.0 110.511 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -161.03 137.5 8.51 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.087 0.955 . . . . 0.0 109.299 172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -151.73 159.6 43.9 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.13 0.972 . . . . 0.0 109.664 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 141.99 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -53.52 119.81 5.33 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.413 0.685 . . . . 0.0 110.166 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.85 87.98 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.28 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.34 146.07 52.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.665 1.732 . . . . 0.0 111.208 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -85.99 159.86 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 10.6 t-20 -125.25 129.09 49.34 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.0 mt -143.68 113.23 5.47 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 168.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.05 152.05 82.67 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.555 1.504 . . . . 0.0 109.247 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 tp -52.5 -36.39 55.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -59.61 -32.33 70.31 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.721 -0.612 . . . . 0.0 112.618 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.07 -33.91 10.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.85 -34.47 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.107 0.867 . . . . 0.0 110.628 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -57.79 -18.24 20.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.562 1.545 . . . . 0.0 113.243 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.23 -43.88 3.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 118.784 0.72 . . . . 0.0 109.784 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -69.63 -29.45 66.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 tp -57.73 -33.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.441 1.018 . . . . 0.0 109.585 177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -18.74 60.63 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 m -108.65 -31.29 7.81 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.906 0.883 . . . . 0.0 110.198 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.94 -35.15 59.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 0.0 111.381 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -145.37 75.84 13.49 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.493 1.917 . . . . 0.0 107.139 -173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.64 -32.31 69.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.398 1.399 . . . . 0.0 111.687 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -65.54 106.74 1.51 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.263 1.025 . . . . 0.0 110.695 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -62.09 -23.31 66.45 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.844 . . . . 0.0 112.469 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.99 6.18 49.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.123 0.969 . . . . 0.0 110.793 -176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.88 144.7 57.09 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.753 -1.217 . . . . 0.0 108.651 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 m -75.15 80.91 2.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.252 0.548 . . . . 0.0 109.956 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 t -72.27 93.37 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -71.48 141.18 50.2 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 139.4 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.6 165.49 30.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.204 1.002 . . . . 0.0 110.813 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 15.4 t -156.11 -169.24 3.0 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.65 2.38 . . . . 0.0 106.359 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.92 -38.43 82.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.844 1.258 . . . . 0.0 110.237 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.89 164.9 27.24 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.997 1.719 . . . . 0.0 108.449 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.9 -9.53 66.33 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.654 -171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.14 -59.72 4.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.621 1.711 . . . . 0.0 111.064 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -73.58 -33.07 64.46 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.277 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.7 p -71.27 -29.73 65.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.773 0.715 . . . . 0.0 111.224 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.38 -46.86 66.91 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -58.25 -44.2 88.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.143 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.48 88.73 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.376 0.989 . . . . 0.0 111.933 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -55.18 -48.15 74.21 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.044 0.838 . . . . 0.0 109.415 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.49 -39.53 64.79 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.698 0.399 . . . . 0.0 110.127 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.7 -50.64 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.607 1.163 . . . . 0.0 109.092 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.2 mt -69.73 -36.24 75.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.35 0.523 . . . . 0.0 111.204 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -70.7 -34.69 72.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.055 0.843 . . . . 0.0 111.323 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -39.74 92.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.874 0.761 . . . . 0.0 110.126 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.9 mtp -61.31 -39.37 90.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.055 0.542 . . . . 0.0 110.826 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.45 7.13 1.28 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.279 -1.289 . . . . 0.0 114.344 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -66.24 128.32 35.65 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.958 1.879 . . . . 0.0 108.426 175.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 p -96.47 -6.51 37.09 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.597 1.159 . . . . 0.0 112.137 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.23 30.76 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.227 0.611 . . . . 0.0 111.736 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.6 m -54.67 149.88 2.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -144.77 121.97 11.52 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.74 111.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 -40.6 55.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.545 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.38 -147.68 18.9 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.0 147.89 17.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -57.27 -28.34 62.9 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.78 -27.14 31.21 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.606 -0.684 . . . . 0.0 112.109 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.25 -35.72 47.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.771 0.714 . . . . 0.0 110.491 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.11 -45.51 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.774 1.23 . . . . 0.0 110.296 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 46.45 32.49 1.61 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.217 1.807 . . . . 0.0 114.545 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.3 mmm -71.83 162.08 75.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.79 0.836 . . . . 0.0 109.088 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.56 135.35 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.21 2.607 . . . . 0.0 112.001 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -114.28 170.74 8.07 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.498 0.719 . . . . 0.0 111.287 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -133.11 143.61 38.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -141.23 163.98 31.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.623 0.769 . . . . 0.0 109.795 -174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.836 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.28 145.05 23.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.983 1.313 . . . . 0.0 108.397 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -140.63 165.97 26.02 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.997 2.119 . . . . 0.0 106.508 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -132.22 126.73 34.21 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -120.07 114.26 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -73.59 87.74 1.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.445 1.898 . . . . 0.0 106.371 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -72.12 -0.93 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.833 0.853 . . . . 0.0 112.434 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 7.4 ttp180 -66.44 165.46 14.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.568 2.347 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -57.02 146.26 60.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.74 -20.04 23.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.438 2.092 . . . . 0.0 112.631 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.27 -39.79 94.66 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.366 -0.834 . . . . 0.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.35 -30.39 42.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.207 0.458 . . . . 0.0 110.811 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -54.6 -41.41 69.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.327 0.651 . . . . 0.0 110.359 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.38 17.81 0.25 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.441 1.096 . . . . 0.0 112.63 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.81 -36.64 1.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.84 1.256 . . . . 0.0 110.86 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.73 143.79 19.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.186 0.994 . . . . 0.0 108.321 175.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -153.57 153.84 33.13 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.88 145.03 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.56 -23.68 67.49 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.191 0.996 . . . . 0.0 112.719 -171.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.12 63.31 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.221 1.391 . . . . 0.0 110.107 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.43 175.49 9.63 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.5 1.52 . . . . 0.0 110.068 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -118.54 151.6 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -116.61 127.86 54.86 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -145.75 126.21 7.2 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -66.4 146.24 79.79 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.941 1.372 . . . . 0.0 109.066 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.75 -36.5 47.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.2 1.0 . . . . 0.0 113.501 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.99 -34.08 72.84 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.214 0.606 . . . . 0.0 112.573 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.07 -38.46 24.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.381 174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.2 t -49.72 -40.88 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.093 0.86 . . . . 0.0 110.549 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -64.43 -1.52 1.78 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -129.24 -47.99 1.2 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.454 1.102 . . . . 0.0 108.495 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -67.63 -21.14 65.4 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.751 1.22 . . . . 0.0 112.867 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.39 -34.25 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.187 1.358 . . . . 0.0 109.63 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.03 72.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.319 0.963 . . . . 0.0 111.696 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -74.54 -43.82 53.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.218 1.007 . . . . 0.0 110.411 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.02 31.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.849 0.859 . . . . 0.0 112.519 -170.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.22 70.58 22.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.801 2.041 . . . . 0.0 107.286 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.66 -29.7 43.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.936 1.757 . . . . 0.0 111.8 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -80.1 99.01 7.51 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.38 -15.66 11.54 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -78.08 -16.42 58.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.076 0.853 . . . . 0.0 112.802 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.8 131.8 46.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.622 1.101 . . . . 0.0 108.497 174.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.9 m -68.25 98.44 0.81 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.88 0.872 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.99 101.51 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -78.81 141.98 37.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.07 136.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -145.7 164.27 32.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.485 0.714 . . . . 0.0 111.119 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 30.9 p -148.61 -145.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.814 1.646 . . . . 0.0 108.644 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.16 -42.0 85.06 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.612 -0.68 . . . . 0.0 110.889 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 -35.63 0.35 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -20.34 0.45 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.391 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -64.51 -49.52 70.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.15 1.975 . . . . 0.0 112.718 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -75.38 -35.87 61.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.288 0.494 . . . . 0.0 109.795 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.177 0.591 . . . . 0.0 111.494 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.16 87.51 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -63.71 -38.82 92.56 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.837 0.319 . . . . 0.0 110.758 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.75 79.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.082 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -60.07 -42.45 94.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.489 1.041 . . . . 0.0 109.89 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.49 -43.31 81.26 Favored 'General case' 0 C--O 1.228 -0.078 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mt -61.36 -44.95 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.428 1.091 . . . . 0.0 110.681 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.2 mt -72.71 -30.13 63.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.129 -0.982 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -65.36 -38.47 90.15 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.31 -40.59 97.77 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.407 1.083 . . . . 0.0 110.105 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -68.92 -3.73 13.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.978 0.911 . . . . 0.0 112.589 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.55 21.27 75.35 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.842 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -63.18 121.48 13.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.314 1.557 . . . . 0.0 107.693 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.8 p -78.75 -17.16 56.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.334 0.653 . . . . 0.0 111.272 -169.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -130.3 119.94 23.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 169.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.41 148.3 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -146.08 149.64 34.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 168.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -92.68 132.33 37.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -118.45 17.21 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.924 0.89 . . . . 0.0 111.445 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.97 -115.13 6.95 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.48 168.79 36.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 117.384 0.592 . . . . 0.0 112.351 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mt -55.61 -26.49 44.35 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -73.21 -12.7 60.96 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -129.7 -12.85 4.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.466 1.107 . . . . 0.0 112.309 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.0 -38.72 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.152 0.981 . . . . 0.0 112.498 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 45.54 55.07 6.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.248 1.419 . . . . 0.0 112.613 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mmm -131.1 160.68 65.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.106 1.763 . . . . 0.0 107.743 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.88 130.71 19.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.456 2.771 . . . . 0.0 112.347 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -136.71 164.68 27.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.852 1.261 . . . . 0.0 110.43 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.45 162.79 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 126.844 2.058 . . . . 0.0 107.48 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -130.13 157.79 41.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.106 0.962 . . . . 0.0 109.83 -169.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.614 -1.103 . . . . 0.0 110.367 -176.306 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.537 0.208 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -151.4 148.64 28.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -143.97 166.12 25.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.448 1.899 . . . . 0.0 107.411 168.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -126.87 109.95 12.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.11 117.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.28 100.52 6.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.032 1.733 . . . . 0.0 107.506 171.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 -2.19 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.107 0.963 . . . . 0.0 112.182 -175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 48' ' ' CYS . 9.4 ttp180 -64.37 166.37 8.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.844 2.458 . . . . 0.0 110.977 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -58.96 146.27 77.3 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.204 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.09 -23.09 25.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.454 2.103 . . . . 0.0 112.747 -171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.84 -31.73 72.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.669 0.787 . . . . 0.0 111.557 -178.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.09 -27.69 32.73 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.515 -0.74 . . . . 0.0 111.439 -178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' A' ' 23' ' ' ASN . 60.0 t80 -57.9 -32.08 67.39 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.442 -0.786 . . . . 0.0 111.053 169.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.24 3.75 3.36 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.361 0.664 . . . . 0.0 112.77 176.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -125.66 -45.83 1.75 Allowed 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.546 1.139 . . . . 0.0 109.355 -172.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -157.37 147.05 20.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -153.58 160.17 42.37 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.744 1.218 . . . . 0.0 109.657 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.13 137.0 25.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -55.31 126.94 27.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.636 0.774 . . . . 0.0 110.061 177.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.34 4.98 89.99 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.914 -0.937 . . . . 0.0 114.349 174.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 177.07 3.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.072 1.436 . . . . 0.0 111.944 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.07 135.89 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 169.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 24.7 t-20 -88.57 126.45 35.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 165.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 mt -140.36 113.61 7.38 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 168.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.13 150.06 85.31 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.672 -1.319 . . . . 0.0 108.672 -176.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.6 tp -53.23 -38.62 63.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -169.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -62.3 -30.07 70.88 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.657 -0.652 . . . . 0.0 112.629 177.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -77.23 -46.6 22.64 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.805 170.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.12 -41.77 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.31 1.044 . . . . 0.0 111.689 -172.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -60.57 -12.8 11.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.74 -41.78 2.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.291 0.951 . . . . 0.0 110.252 169.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -68.56 -30.77 69.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 118.092 -0.956 . . . . 0.0 112.681 -172.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 tp -60.06 -33.07 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 119.918 1.236 . . . . 0.0 109.492 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.49 63.81 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 m -98.84 -35.13 10.21 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.793 0.837 . . . . 0.0 110.046 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.21 -35.82 58.89 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.206 0.603 . . . . 0.0 111.715 -176.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -143.89 74.33 16.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.881 2.072 . . . . 0.0 107.017 -173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.33 -22.5 52.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.237 1.958 . . . . 0.0 112.259 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -72.47 99.38 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.479 0.711 . . . . 0.0 109.807 173.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.02 -14.84 39.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.0 4.52 53.7 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.399 1.0 . . . . 0.0 111.098 178.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.03 145.68 53.32 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 120.573 -1.33 . . . . 0.0 108.933 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.6 m -81.91 84.28 6.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.508 1.147 . . . . 0.0 109.874 169.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.86 97.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 167.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -69.07 141.2 54.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.88 134.9 65.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -145.45 163.18 35.46 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.007 0.923 . . . . 0.0 110.266 176.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 22.6 p -149.5 -155.7 0.65 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.585 1.954 . . . . 0.0 107.528 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.93 -50.12 67.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.538 1.063 . . . . 0.0 111.754 -177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.48 -7.46 3.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -167.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.2 -26.94 6.88 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.198 0.908 . . . . 0.0 114.04 169.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -62.39 -44.71 95.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.051 1.425 . . . . 0.0 112.177 -172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -72.19 -30.52 65.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.076 -0.488 . . . . 0.0 109.695 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -45.24 94.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.745 0.818 . . . . 0.0 110.694 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.39 86.96 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -59.82 -43.78 94.35 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.777 174.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.19 92.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.205 0.911 . . . . 0.0 111.272 176.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -40.43 94.11 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.153 0.433 . . . . 0.0 109.944 -178.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -70.39 -46.0 64.87 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.658 1.183 . . . . 0.0 109.006 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.31 -46.43 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.549 1.14 . . . . 0.0 109.818 178.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.2 mt -72.07 -33.24 67.76 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.545 -0.722 . . . . 0.0 111.081 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -61.91 -41.34 97.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.784 0.72 . . . . 0.0 109.955 172.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.67 -36.79 84.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.201 1.001 . . . . 0.0 111.08 176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.8 mtp -69.63 -5.52 25.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.392 1.077 . . . . 0.0 112.575 171.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.67 15.05 55.84 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.219 -1.323 . . . . 0.0 113.154 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -66.11 123.71 20.63 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.899 1.85 . . . . 0.0 106.593 168.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -91.81 -11.29 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.88 0.872 . . . . 0.0 112.261 -168.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.4 16.07 2.76 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -56.82 152.0 2.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.739 0.816 . . . . 0.0 109.559 171.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.85 140.54 28.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.27 111.77 21.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -175.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.72 23.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.428 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.29 -146.02 18.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.55 150.57 16.9 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.6 -31.72 64.55 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.049 1.34 . . . . 0.0 111.992 -171.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -62.96 -15.94 57.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -124.67 -19.05 5.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.579 1.151 . . . . 0.0 111.971 -176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.66 133.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.53 23.07 15.07 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.492 1.117 . . . . 0.0 112.399 -175.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mmm -73.28 155.63 89.74 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.06 145.4 33.81 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.255 2.637 . . . . 0.0 111.898 170.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -110.77 163.74 13.47 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 110.163 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.11 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 165.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -126.72 152.02 47.37 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.919 0.888 . . . . 0.0 108.96 -168.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -172.325 . . . . . . . . 0 0 . 1 stop_ save_